hg_181054.1

Basic information about the TSS

---

TSS ID: hg_181054.1 Species: human Chr: chr19		Start: 41353856 End: 41353870 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: X02812 Distance: -13 GeneID: 7040 HGNC/MGI_ID: HGNC:11766 UniProt_ID:

Gene_name: transforming growth factor beta 1 Gene_symbol: TGFB1 Gene_synonyms: CED TGFbeta Gene_source: HGNC:11766

TATA-Box annotation

---

Distance to TSS:	20
Nearest PromoterID:	NM_000660
Entrez ID:	7040
Nearest Unigene:	Hs.645227
Nearest Refseq:	NM_000660
Nearest Ensembl:	ENSG00000105329
Gene Name:	transforming growth factor beta 1
Gene Alias:	CED
Gene Description:	transforming growth factor beta 1
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.820896
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TGFB1 p2@TGFB1 p3@TGFB1 p4@TGFB1 p5@TGFB1 p8@TGFB1 p9@TGFB1 p10@TGFB1
Sample		p1@TGFB1	p2@TGFB1	p3@TGFB1	p4@TGFB1	p5@TGFB1	p8@TGFB1	p9@TGFB1	p10@TGFB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7.60	6.04	1.75	2.14	0.39	0.19	0.58	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.28	4.65	1.82	2.02	1.82	0.20	1.42	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.14	4.44	1.35	1.93	0.77	0.39	0.39	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.86	4.57	1.25	1.66	0.42	0.00	0.21	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	10.57	3.60	1.35	1.80	1.35	0.45	0.45	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.30	4.26	1.16	0.97	0.39	0.00	0.97	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.77	6.97	2.40	2.18	0.65	0.65	0.87	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.20	4.12	1.45	2.66	0.97	0.00	1.45	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	9.40	4.49	0.21	1.28	1.28	0.21	0.43	2.56
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	5.80	1.74	0.00	0.00	1.74	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.02	2.02	0.40	0.40	0.81	0.40	0.40	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.03	2.85	0.00	0.41	0.41	0.41	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	48.68	10.96	7.25	6.13	2.74	0.81	0.81	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.69	9.17	4.36	4.66	2.10	2.10	0.90	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.93	12.95	3.29	5.49	2.85	2.20	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.77	12.07	5.03	5.78	2.01	2.77	0.50	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	42.81	10.05	3.28	5.46	1.75	1.31	1.31	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.98	10.55	6.33	5.91	2.95	2.95	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	42.12	8.53	4.80	2.13	4.27	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	38.51	12.04	5.12	7.82	3.31	1.81	1.35	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	46.51	10.83	5.48	4.95	2.67	1.47	0.67	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	44.36	13.29	5.35	5.35	3.11	1.55	2.24	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.40	10.60	3.49	4.65	2.33	1.81	1.94	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	42.71	11.89	5.58	6.79	2.67	1.46	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.99	13.93	3.10	5.42	2.06	1.81	0.52	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	50.64	12.98	6.33	5.06	2.53	1.90	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	37.91	13.19	6.59	5.49	1.10	3.85	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	52.34	26.17	6.37	5.42	4.24	1.18	1.89	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	45.55	17.93	3.55	8.08	4.04	1.78	1.29	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	39.09	18.28	4.71	6.70	3.26	2.17	1.27	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	42.71	16.54	3.35	6.49	2.30	1.88	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.75	16.41	1.95	5.47	2.74	1.37	1.95	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	53.18	18.36	5.91	9.29	3.38	4.64	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	42.39	18.47	4.62	11.88	2.64	3.46	1.65	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	44.32	22.63	2.43	7.29	2.80	3.18	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.29	19.35	4.98	4.79	2.68	2.11	1.15	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	40.26	24.12	5.93	5.52	3.88	2.25	1.23	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	50.17	20.75	3.83	8.26	4.03	3.22	1.21	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	49.97	20.80	3.78	6.21	1.89	2.43	1.08	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	42.49	18.24	3.60	4.80	4.32	1.68	1.44	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	46.35	19.06	4.47	5.88	1.65	1.88	1.18	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.74	17.27	4.54	8.64	2.34	1.76	0.59	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	36.48	20.25	4.43	5.91	2.74	2.53	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.59	20.11	3.50	5.42	3.67	2.10	0.87	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.92	21.68	3.21	5.62	1.41	1.41	1.41	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.36	18.38	2.79	4.65	2.09	3.49	2.09	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	42.94	17.99	2.88	6.48	2.40	2.64	2.16	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	41.43	19.67	3.87	5.07	1.19	0.30	0.89	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	34.71	19.39	4.55	5.27	4.55	1.68	0.48	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	35.18	18.40	4.65	5.66	3.84	1.01	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.68	16.60	4.30	11.07	1.43	2.05	0.82	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.68	20.46	2.89	7.34	1.11	1.11	2.45	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.52	17.74	2.48	5.32	1.77	1.77	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.55	12.59	0.99	6.30	4.64	2.65	1.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	11.75	0.00	22.65	2.52	2.52	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	13.78	1.38	11.48	2.76	0.92	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.64	11.67	2.59	6.48	4.54	0.65	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.88	9.96	2.25	5.78	3.53	0.64	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.71	12.57	2.51	6.29	3.46	3.14	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	7.05	1.41	3.53	2.82	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	14.58	4.49	5.05	3.93	1.12	0.00	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	16.72	1.59	8.76	1.59	3.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.76	12.57	1.36	5.10	1.36	2.72	0.68	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	13.97	3.90	8.12	2.27	3.57	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.78	11.00	6.03	4.61	1.77	3.19	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	23.69	23.69	7.90	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.86	26.81	4.88	5.85	6.83	2.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	14.88	3.47	6.45	3.47	2.48	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	18.30	5.16	6.57	5.16	1.88	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.26	23.51	4.64	6.95	2.65	2.98	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	22.58	26.91	5.26	8.35	3.09	3.40	0.31	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.07	25.99	5.20	5.81	5.50	1.83	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	32.15	9.03	3.17	2.38	1.90	0.63	0.48	1.11
Adipocyte - breast, donor2	11327-117E4	32.73	9.47	3.05	5.61	0.96	2.73	0.80	0.80
Adipocyte - omental, donor1	11473-119C6	18.70	6.23	1.91	2.16	1.02	0.25	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	18.69	13.45	3.74	2.24	0.75	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	7.03	6.03	2.01	1.34	0.00	1.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.93	3.83	1.28	1.91	0.64	0.64	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	34.78	19.42	2.71	2.71	1.35	1.35	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	21.20	6.08	1.22	1.04	1.22	0.17	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	69.23	12.32	3.52	1.37	2.15	0.98	0.20	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	49.67	14.41	4.12	2.06	1.03	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	50.74	10.31	2.79	2.79	2.23	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	31.15	13.52	4.70	1.18	1.76	0.00	2.35	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	26.86	7.00	2.65	1.29	1.05	0.16	0.08	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	46.80	10.33	1.94	0.97	0.65	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	18.66	4.80	2.13	4.80	1.60	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	21.14	2.23	0.56	1.11	1.11	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.23	2.50	1.66	1.25	0.42	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	23.86	5.02	1.51	2.51	1.26	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	20.29	6.22	1.96	2.29	0.00	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	3.65	1.83	0.30	1.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	83.10	4.20	2.43	2.87	0.88	0.44	2.21	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	16.14	2.51	0.72	2.15	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	116.21	14.38	2.40	9.58	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	16.91	3.42	2.70	1.98	2.52	0.36	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	36.82	6.69	3.35	5.02	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	31.43	8.01	3.29	1.85	3.08	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	29.52	4.23	3.89	2.17	2.29	0.23	0.11	0.34
Anulus Pulposus Cell, donor2	11463-119B5	19.35	5.63	2.45	3.43	2.69	0.00	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	39.09	6.29	3.15	8.99	0.90	0.00	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	50.79	5.21	2.17	9.55	3.47	1.30	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	6.42	4.28	6.42	0.00	4.28	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	41.85	5.08	1.20	11.66	2.09	1.20	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	34.15	10.12	2.53	22.76	3.79	3.79	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	36.30	5.94	1.32	7.26	0.00	1.98	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	43.86	6.17	1.95	3.57	1.30	1.30	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	37.86	6.80	1.94	5.83	1.46	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.79	4.16	4.75	5.94	0.00	1.19	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	36.53	5.27	3.77	7.91	1.88	0.75	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	42.81	3.63	0.00	7.98	1.45	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	37.61	6.27	1.25	5.02	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	73.47	4.61	3.79	1.81	2.14	0.00	1.32	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	6.82	4.09	9.55	0.00	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.99	4.37	1.36	1.06	1.06	0.30	0.90	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	36.43	8.04	2.14	10.18	1.07	1.07	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	54.22	6.61	1.70	6.42	1.70	0.19	1.51	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	61.21	4.54	4.01	11.23	0.53	0.80	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	44.87	5.85	2.93	12.68	1.95	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	54.07	7.80	1.99	3.81	1.99	0.83	0.66	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	45.63	2.40	3.60	9.61	1.20	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	3.54	7.08	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	62.61	7.72	3.26	4.80	2.92	0.86	0.51	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	0.00	0.00	4.19	0.00	0.00	0.00	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	40.29	6.31	0.97	10.19	0.97	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	63.75	9.49	2.28	9.11	2.66	0.76	0.76	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	7.27	1.21	9.69	3.63	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	35.34	9.12	5.13	5.70	2.28	1.14	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	61.99	7.91	3.63	7.27	1.50	1.50	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	45.68	4.13	2.84	5.16	1.29	1.81	0.77	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	36.60	7.04	1.88	7.51	1.88	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	56.91	6.75	2.57	8.04	1.93	1.61	0.00	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	50.66	7.13	4.99	3.57	1.43	0.71	1.43	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	43.87	5.26	2.92	4.68	1.17	2.34	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	50.28	6.62	2.11	5.72	3.31	0.90	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	35.64	9.50	2.38	5.94	1.19	2.38	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	38.65	9.15	3.05	11.19	1.02	1.02	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	56.80	7.90	2.04	10.95	2.04	2.29	0.51	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	37.49	5.72	2.54	8.26	1.27	0.64	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	35.39	6.04	2.16	7.34	1.29	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	48.90	8.47	1.91	4.45	0.85	0.85	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	41.47	6.09	1.74	3.77	0.29	0.87	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	42.51	9.45	0.94	9.45	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	53.23	8.48	3.56	4.07	1.02	0.51	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	0.00	6.95	11.58	2.32	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	61.26	12.68	4.23	2.11	0.00	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	46.96	5.57	2.14	4.07	2.79	0.43	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	41.51	3.01	4.81	6.62	1.20	0.60	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	27.70	7.29	1.46	6.56	0.73	1.46	0.00	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	64.37	10.34	1.84	6.90	1.84	1.61	1.38	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	40.80	7.65	0.00	2.55	0.00	10.20	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.61	4.58	1.78	1.02	1.02	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	59.04	6.81	4.13	4.54	2.06	1.24	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	41.62	4.90	1.22	7.34	1.22	2.14	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	37.28	4.30	2.87	11.95	1.91	0.96	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	55.44	8.87	2.88	5.32	1.77	0.89	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	3.05	4.58	6.10	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.71	6.09	2.77	4.43	1.11	0.55	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	37.60	7.15	1.85	4.50	1.85	0.53	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	29.80	5.82	2.91	4.72	1.82	1.45	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	21.86	4.30	3.56	0.98	2.46	0.25	0.61	0.37
Astrocyte - cerebellum, donor2	11580-120F5	37.83	9.76	6.16	4.96	4.11	0.68	1.03	0.51
Astrocyte - cerebellum, donor3	11661-122F5	35.45	5.87	3.15	2.31	2.94	0.42	0.00	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	19.87	2.09	3.14	1.74	0.70	0.00	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	27.83	5.99	3.40	2.26	2.26	0.49	0.65	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	50.27	7.76	4.47	3.88	3.28	0.75	1.19	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	176.27	22.94	18.58	14.57	12.39	2.64	3.44	3.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	172.26	22.05	18.92	9.77	12.40	1.00	7.02	4.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	141.34	21.39	13.43	9.79	9.90	2.28	4.89	4.10
Basophils, donor1	12241-129G9	205.30	21.97	18.57	8.11	14.91	9.15	1.83	0.52
Basophils, donor2	12242-129H1	264.10	14.07	35.00	10.10	36.80	3.61	2.53	1.08
Basophils, donor3	12243-129H2	337.21	26.90	27.34	8.08	26.02	6.32	2.06	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	34.71	10.13	1.94	1.94	3.02	0.65	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	116.58	35.66	5.49	15.09	7.31	3.20	2.29	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	7.17	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	59.00	5.65	3.77	1.26	3.77	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	102.10	15.60	5.61	4.99	2.70	1.25	1.25	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	78.30	17.27	4.38	5.30	2.53	0.23	1.38	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	36.35	14.22	1.44	3.78	1.26	0.90	0.36	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	54.93	0.62	1.55	1.85	1.55	0.41	7.63	2.47
Burkitt's lymphoma cell line:RAJI	10476-106I8	69.17	2.79	2.10	3.03	2.79	0.23	9.08	5.12
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	54.04	12.79	1.92	0.96	2.24	0.32	4.48	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	0.00	0.00	0.00	10.34	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	261.49	20.29	31.00	6.76	20.85	2.82	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	450.08	28.21	41.39	26.36	24.87	6.31	0.74	0.93
CD14+ Monocytes, donor3	11381-118B4	308.23	23.93	24.37	12.07	19.98	8.78	0.44	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	187.38	9.06	4.25	8.49	1.70	1.70	2.55	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	188.40	7.20	6.07	9.48	1.52	1.52	1.52	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	202.18	9.20	6.25	7.23	1.97	0.33	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	354.87	29.92	16.19	37.58	8.53	15.47	1.45	1.73
CD14+ monocytes - mock treated, donor2	11873-125C1	340.06	30.78	12.67	31.98	8.15	11.16	2.41	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	393.24	34.59	15.40	27.72	10.66	10.19	1.42	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	319.23	18.75	13.06	32.81	6.03	8.20	1.00	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	375.65	28.98	9.94	37.26	7.45	9.38	0.55	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	408.09	24.05	11.40	26.28	7.19	7.44	0.50	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	476.58	26.82	11.36	43.86	5.29	10.96	1.17	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	546.61	34.54	13.00	39.17	9.44	10.15	0.53	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	397.83	19.15	10.88	24.81	7.18	10.23	1.31	1.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	184.49	13.35	11.94	12.17	6.32	3.75	1.87	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	249.76	13.73	8.45	15.84	4.75	8.45	2.11	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	255.15	18.86	13.31	12.20	2.22	3.33	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	395.97	24.84	16.06	41.65	6.99	16.81	2.83	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	416.26	28.93	12.57	39.51	7.78	9.98	2.20	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	233.81	18.32	9.99	15.82	6.04	9.16	0.83	1.87
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	555.95	31.11	13.96	52.62	5.49	15.33	4.35	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	432.73	24.20	13.57	19.68	7.24	7.24	3.85	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	441.26	23.13	12.66	32.30	9.17	6.55	3.06	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	397.84	19.37	17.75	45.73	6.72	7.80	1.08	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	600.67	35.76	19.89	50.24	7.33	12.21	3.49	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	566.00	25.67	18.94	48.39	11.78	13.05	2.10	4.63
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	357.32	21.49	8.63	26.64	5.88	9.37	0.92	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	468.16	31.70	9.86	30.65	8.81	4.93	0.35	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	456.27	22.37	10.53	29.83	6.14	9.65	3.07	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	399.14	27.20	13.25	37.49	6.10	8.89	0.87	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	441.55	26.39	11.52	46.09	8.18	8.92	2.60	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	345.09	20.48	17.68	24.79	9.92	7.54	0.43	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	220.71	14.33	10.65	18.84	2.46	5.73	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	233.65	15.53	11.36	10.89	9.04	6.49	0.93	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	189.31	10.90	7.19	9.05	3.94	5.57	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	85.22	12.21	7.85	10.03	6.32	17.00	0.87	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	142.99	21.48	10.86	11.55	9.93	21.02	0.69	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	76.47	10.61	4.98	2.38	4.77	16.90	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	288.24	17.75	10.74	11.99	6.54	18.06	0.78	1.87
CD14+CD16- Monocytes, donor2	11799-124C8	222.32	14.15	10.48	13.45	2.45	10.48	1.05	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	234.79	25.86	11.59	10.93	6.47	10.93	0.67	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	80.12	17.61	10.21	1.53	5.87	49.25	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	100.12	22.83	11.20	6.37	9.44	37.55	0.88	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	60.01	14.95	9.69	2.32	6.95	30.11	1.47	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	97.55	0.00	0.00	4.06	4.06	4.06	6.10	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	103.73	2.71	4.07	2.03	4.07	3.39	2.03	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	97.35	4.14	0.00	0.00	3.11	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	97.01	1.60	5.86	0.53	3.73	2.13	2.67	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	106.14	1.07	5.90	4.29	3.75	1.07	1.61	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	78.62	0.70	4.21	0.70	2.11	2.81	2.81	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	105.89	2.35	3.92	2.35	4.71	3.92	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	83.05	1.32	3.95	1.32	5.27	3.95	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	135.61	3.29	13.97	9.04	11.51	1.64	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	198.04	5.80	24.66	15.96	13.06	2.18	0.73	3.63
CD19+ B Cells, donor3	11705-123B4	178.20	3.53	19.18	11.61	12.62	4.04	2.02	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.51	0.81	1.62	2.42	1.21	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.39	1.20	0.80	1.20	0.00	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	51.21	10.04	3.01	0.00	3.01	3.01	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	136.52	16.85	15.17	6.74	15.73	1.69	3.37	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.99	9.77	2.25	0.75	1.13	0.38	5.64	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	54.34	10.37	2.03	1.58	2.25	0.00	2.93	2.03
CD4+ T Cells, donor1	11225-116C1	437.39	11.78	52.49	10.71	38.21	1.79	1.79	0.71
CD4+ T Cells, donor2	11306-117C1	511.32	12.86	36.74	54.50	37.35	14.70	1.22	2.45
CD4+ T Cells, donor3	11382-118B5	416.32	10.98	31.11	34.46	27.45	10.37	2.13	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	140.12	8.42	14.55	12.00	10.46	5.87	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	181.25	8.98	25.60	7.41	11.23	4.04	0.22	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	210.42	6.32	21.85	9.20	16.96	4.31	1.72	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	110.46	4.27	14.22	2.37	14.22	1.90	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	87.79	2.81	9.83	4.21	16.15	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	115.37	3.30	9.89	6.59	13.18	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	173.13	11.13	14.16	16.33	6.65	9.54	0.87	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	200.98	11.69	18.47	14.23	8.98	5.76	1.53	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	155.40	11.12	15.31	10.16	9.83	4.84	1.61	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	176.18	2.69	15.69	8.07	8.07	4.48	2.24	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	180.28	4.54	15.72	8.39	9.43	5.94	0.70	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	166.75	2.64	16.28	11.00	11.88	6.60	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	165.70	10.12	8.43	11.38	7.17	11.81	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	167.25	17.24	9.97	9.35	5.82	5.82	2.29	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	143.67	12.03	8.69	16.04	4.01	6.68	1.34	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	192.26	6.53	13.87	8.97	7.61	2.18	1.63	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	139.88	5.90	10.18	7.50	14.47	0.54	0.54	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	138.08	5.38	12.55	10.76	17.93	5.38	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	253.48	15.39	17.06	11.31	9.46	12.79	1.30	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	197.34	12.13	16.03	9.10	8.23	11.05	1.08	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	262.69	14.92	20.59	11.14	10.30	13.03	1.89	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	219.43	8.09	18.20	7.08	16.18	4.04	0.51	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	172.87	9.53	15.16	6.07	9.96	2.60	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	162.12	11.33	15.69	16.56	16.13	5.67	2.18	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	238.53	7.42	18.31	4.45	12.87	4.95	4.45	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	179.10	0.92	11.08	7.39	15.69	5.54	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	167.50	4.19	15.35	4.19	6.98	4.19	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	204.37	9.42	17.17	14.12	21.05	7.20	1.11	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	236.07	10.06	19.88	14.48	23.07	3.68	3.19	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	190.96	7.70	12.32	7.70	4.62	6.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	276.47	7.52	17.91	14.32	21.13	8.59	2.15	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	207.75	12.46	16.62	4.15	18.00	9.69	5.54	1.38
CD8+ T Cells, donor1	11226-116C2	792.30	20.30	60.24	24.88	87.74	6.88	6.22	3.27
CD8+ T Cells, donor2	11307-117C2	834.96	18.02	60.07	88.98	79.97	19.90	5.63	6.76
CD8+ T Cells, donor3	11383-118B6	582.75	15.65	48.23	30.80	61.35	7.83	7.07	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.11	4.59	0.92	0.69	0.92	0.23	3.21	3.44
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.59	3.83	0.24	1.92	0.96	0.48	2.88	5.51
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.84	3.28	1.37	1.09	0.82	0.27	3.83	3.83
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.70	3.60	0.60	3.30	1.20	0.30	1.20	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.68	6.00	1.68	1.20	0.72	0.00	2.40	5.52
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.64	5.68	2.05	1.82	0.91	0.68	2.50	3.41
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.43	5.65	1.74	1.09	1.30	1.09	3.04	4.78
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.21	7.63	3.16	2.37	1.58	1.05	4.47	4.74
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.13	6.80	2.35	3.52	0.47	0.94	3.28	4.46
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.36	6.94	0.91	2.72	0.91	1.21	2.72	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.04	5.81	1.16	2.32	0.58	0.87	2.91	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.39	5.86	0.80	2.93	1.60	0.27	1.60	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	39.40	8.76	3.06	2.63	1.31	1.31	1.31	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	45.09	11.39	2.73	1.82	1.82	0.00	0.46	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.06	11.93	2.98	2.24	2.98	0.00	3.73	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.04	8.28	2.52	1.44	1.08	1.08	4.32	5.40
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.92	3.16	1.73	1.15	2.88	0.00	2.30	3.74
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	11.55	6.13	1.65	1.65	1.41	0.24	5.19	4.01
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.48	7.61	1.90	2.54	2.22	0.00	3.17	5.39
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.15	10.15	1.23	2.77	2.77	0.00	3.69	7.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.14	8.66	1.92	1.92	0.64	0.64	3.85	7.69
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	7.27	2.68	0.38	0.38	0.38	1.53	3.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.49	4.34	0.39	2.36	1.58	0.39	1.58	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.05	4.54	0.76	1.51	0.00	0.76	0.76	5.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	8.83	2.41	2.41	2.41	0.00	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	50.36	5.60	3.50	2.80	1.40	0.70	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	42.07	8.01	1.00	1.00	1.00	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	98.70	23.76	10.97	1.83	5.48	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	72.63	14.33	1.48	7.41	4.45	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	56.62	7.68	2.53	1.79	3.26	1.26	0.32	0.53
Chondrocyte - de diff, donor1	11261-116G1	29.81	14.56	1.73	5.20	3.81	1.73	1.04	1.73
Chondrocyte - de diff, donor2	11338-117F6	93.46	16.35	4.98	3.55	4.62	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	66.33	11.83	2.39	6.37	2.39	2.16	0.91	0.00
Chondrocyte - re diff, donor2	11339-117F7	179.95	38.50	8.06	6.27	5.37	0.00	1.79	2.69
Chondrocyte - re diff, donor3	11411-118E7	104.34	29.93	4.04	3.24	3.64	1.21	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	48.08	22.84	7.12	3.79	6.31	0.57	2.64	2.18
Ciliary Epithelial Cells, donor2	11323-117D9	78.24	38.48	8.12	12.18	5.34	2.14	3.42	3.63
Ciliary Epithelial Cells, donor3	11399-118D4	94.87	37.08	5.40	5.66	7.43	1.59	4.25	3.10
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	56.30	11.92	3.85	3.67	2.20	0.46	0.09	0.28
Corneal Epithelial Cells, donor1	11526-119I5	56.65	11.64	1.98	2.42	3.51	0.22	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	29.58	5.69	2.28	3.41	3.41	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	40.13	8.95	1.79	2.81	2.05	0.51	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	85.68	37.97	3.30	2.64	2.48	0.99	0.17	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	81.69	33.75	2.84	0.32	3.47	0.63	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	10.35	3.45	0.00	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	76.02	38.77	2.59	6.59	3.56	1.40	0.54	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	183.80	17.42	21.18	7.17	12.98	1.02	3.07	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	109.03	13.71	16.97	1.31	5.22	0.00	1.96	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	83.72	16.45	10.16	4.36	10.16	1.45	1.94	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	181.44	12.01	4.17	3.17	2.67	0.33	1.67	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	115.59	17.60	3.52	5.28	1.76	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	241.79	18.95	4.81	7.07	2.26	0.85	0.28	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	282.70	16.12	7.08	3.93	3.54	0.79	1.57	2.36
Endothelial Cells - Artery, donor1	11264-116G4	162.89	18.62	3.49	12.51	0.87	2.04	0.87	2.04
Endothelial Cells - Artery, donor2	11341-117F9	395.50	20.23	4.24	35.29	2.82	11.29	3.06	2.12
Endothelial Cells - Artery, donor3	11413-118E9	214.93	15.25	3.16	9.47	2.98	0.70	2.63	1.93
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.41	8.64	2.22	1.99	1.33	0.44	0.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	55.68	10.95	0.30	1.22	0.61	0.30	0.91	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	61.74	15.22	1.97	2.82	0.56	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	114.69	8.62	3.57	7.13	1.19	1.19	1.19	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	153.60	7.81	3.64	3.64	1.56	1.04	1.04	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	91.17	9.07	2.55	6.10	2.27	2.13	1.99	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	134.84	8.80	2.40	5.20	2.40	3.20	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	256.82	19.92	3.67	31.97	0.52	4.72	1.57	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	132.70	13.92	3.73	5.34	2.36	1.99	2.61	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	116.67	21.73	3.48	2.39	2.39	0.43	1.52	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	158.28	22.96	3.91	3.54	4.27	0.24	1.83	1.22
Endothelial Cells - Vein, donor1	11267-116G7	226.36	23.89	4.55	3.41	4.55	0.00	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	268.92	12.57	4.19	4.19	2.79	0.70	2.10	5.59
Endothelial Cells - Vein, donor3	11416-118F3	252.31	15.70	1.88	9.11	4.08	1.26	1.57	1.41
Eosinophils, donor1	12244-129H3	167.72	0.00	15.25	0.00	30.49	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	638.65	49.51	146.87	16.50	70.96	54.46	3.30	1.65
Eosinophils, donor3	12246-129H5	449.42	39.24	71.34	3.57	17.83	60.64	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	52.29	10.51	2.20	1.95	0.98	1.22	0.98	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	24.96	8.32	2.08	6.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.51	16.42	5.34	1.23	6.57	0.82	0.00	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.33	1.75	0.66	3.18	0.66	0.77	0.55	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	33.80	1.63	4.33	9.97	3.79	2.60	0.87	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	117.52	8.13	5.09	8.85	4.12	1.94	0.97	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.38	3.14	0.82	1.23	0.14	0.27	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	61.38	6.86	3.80	7.38	2.53	2.11	0.84	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	67.19	37.15	2.63	10.01	1.05	1.58	1.32	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	118.60	15.61	5.98	9.63	3.65	1.99	2.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	62.60	15.88	3.18	5.90	2.27	1.36	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	199.34	17.43	6.82	4.55	6.06	3.03	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	199.20	25.87	6.62	13.72	6.78	3.15	1.58	1.42
Fibroblast - Cardiac, donor4	11452-119A3	70.62	14.55	2.12	2.42	1.82	0.61	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	92.64	10.91	4.06	8.76	2.66	1.02	0.89	1.14
Fibroblast - Cardiac, donor6	11460-119B2	81.56	13.34	3.03	6.52	2.58	0.61	0.15	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	76.51	25.86	8.17	4.02	6.30	0.54	1.07	2.01
Fibroblast - Choroid Plexus, donor2	11572-120E6	90.17	34.51	7.77	7.77	4.75	2.59	1.73	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	213.86	43.94	8.79	24.90	4.39	5.86	5.86	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	31.14	9.23	3.23	1.15	2.77	0.69	1.15	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	41.04	6.44	4.07	3.05	2.54	0.68	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	13.15	5.87	0.94	1.64	1.88	0.00	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	56.60	5.66	3.77	2.36	4.72	0.94	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	33.36	10.40	3.75	3.26	1.57	0.73	1.33	0.48
Fibroblast - Dermal, donor4	11450-119A1	24.08	2.71	2.15	4.07	1.58	0.45	1.36	0.68
Fibroblast - Dermal, donor5	11454-119A5	32.62	4.01	3.84	4.19	2.09	0.70	1.40	1.40
Fibroblast - Dermal, donor6	11458-119A9	31.67	4.39	3.41	4.22	2.27	0.81	2.11	1.79
Fibroblast - Gingival, donor1	11237-116D4	31.23	6.87	3.75	0.83	1.67	0.62	0.83	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	72.84	13.62	10.22	4.72	5.76	0.26	1.31	0.52
Fibroblast - Gingival, donor2	11318-117D4	29.78	3.29	2.77	3.56	1.58	0.66	0.66	0.26
Fibroblast - Gingival, donor3	11394-118C8	67.87	11.80	5.61	4.35	4.54	0.77	0.68	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	77.92	27.01	11.43	7.27	6.23	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	65.37	14.10	4.93	6.52	1.94	1.41	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	98.21	15.12	7.48	4.99	6.39	0.78	1.25	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	57.07	7.57	6.76	4.19	2.57	1.49	0.95	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	193.38	23.64	18.35	2.47	9.88	0.00	1.06	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	61.42	14.62	6.00	3.51	1.90	0.44	0.88	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	93.27	15.68	8.86	7.36	5.05	0.95	0.95	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	116.71	20.95	8.67	7.68	6.14	1.54	0.33	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.54	19.37	6.75	7.92	2.79	1.17	0.88	1.03
Fibroblast - Lung, donor1	11270-116H1	57.09	14.95	4.08	5.44	4.08	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	2.98	1.49	2.98	2.98	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	35.45	9.92	3.17	4.22	3.17	1.27	1.90	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	100.80	27.49	14.16	2.50	3.33	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	64.34	16.78	5.59	0.00	4.20	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	58.49	10.92	5.04	6.44	2.80	0.56	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	107.18	24.36	7.71	3.65	8.12	0.41	1.62	1.22
Fibroblast - Mammary, donor2	11620-122A9	31.95	0.00	3.99	3.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	11.91	23.83	0.00	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	21.53	1.36	2.13	0.97	2.52	0.00	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	56.73	8.34	5.16	5.76	3.19	1.06	0.46	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	39.47	8.26	3.67	1.22	3.37	0.00	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	89.68	24.42	6.49	3.82	6.87	0.38	1.14	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	66.96	8.10	4.32	10.26	2.16	1.35	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	57.29	13.45	4.75	3.48	1.97	0.70	0.58	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	97.49	9.06	2.65	4.31	3.87	0.77	0.44	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	112.16	29.26	12.80	3.86	5.69	1.02	1.02	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	59.47	7.35	4.01	2.00	4.01	0.67	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	32.02	8.30	2.77	1.98	2.77	0.00	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	102.60	42.07	3.37	11.51	0.79	1.39	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	48.13	12.79	2.66	3.02	3.73	0.71	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.95	13.60	3.15	3.74	2.17	0.99	0.99	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	105.90	60.17	2.71	9.03	0.60	2.11	0.60	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	59.05	20.29	4.32	6.05	4.53	1.08	0.43	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.78	26.07	1.01	8.35	0.00	0.76	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	67.11	15.92	5.58	6.56	4.59	2.13	0.49	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	178.25	66.77	2.61	8.42	1.40	1.60	1.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	153.31	37.57	9.24	15.87	9.85	3.01	1.11	1.81
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.00	30.83	2.42	9.07	1.21	1.51	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	65.70	11.52	5.80	3.15	2.73	0.58	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	68.89	20.00	7.35	11.80	7.01	1.71	0.17	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	80.47	61.42	0.33	11.17	0.33	1.97	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	85.75	18.75	4.69	9.27	7.24	1.81	0.85	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	92.94	14.84	4.89	6.07	5.90	1.35	1.35	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	32.78	12.55	4.39	19.60	3.29	4.23	0.00	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	16.56	5.23	2.61	2.61	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	50.97	4.16	3.12	1.39	1.21	0.87	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	58.81	3.90	0.78	2.08	1.56	0.52	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.23	6.64	2.56	1.28	3.07	0.51	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	4.59	0.77	0.77	0.77	0.77	9.19	10.72
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.04	4.47	2.55	0.64	0.00	1.91	9.57	15.31
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.42	5.13	0.57	0.86	0.57	0.57	4.28	6.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.65	1.65	0.55	0.83	0.00	0.00	0.55	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.88	2.97	0.23	0.46	0.00	0.23	1.60	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.96	4.76	1.19	0.40	0.59	0.00	4.56	5.35
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.85	1.59	0.00	0.53	0.26	0.00	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.28	1.30	1.30	0.33	0.00	0.00	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	0.88	1.77	0.44	0.88	0.44	0.00	3.98	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.80	4.80	0.85	1.84	0.99	0.71	2.69	5.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	29.55	8.74	1.72	4.06	2.83	0.62	2.22	4.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	15.31	2.69	1.34	1.34	2.15	0.54	4.30	5.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	88.34	20.94	7.68	9.17	6.94	3.10	6.07	3.59
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	58.83	13.43	5.12	8.44	4.98	1.66	7.20	8.31
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	63.02	14.84	4.88	10.98	3.25	1.63	9.35	9.35
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	94.01	20.99	7.07	8.21	4.79	1.83	4.79	3.65
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	85.20	14.08	5.85	9.47	4.24	1.87	4.48	4.73
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	112.35	18.14	5.46	8.09	6.34	1.97	2.84	6.12
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	70.03	14.48	5.02	10.34	2.95	1.18	4.43	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	57.86	8.27	2.54	6.52	4.93	0.79	2.54	3.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	132.93	27.03	5.14	8.71	3.57	1.56	6.48	4.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.85	7.86	3.23	4.64	2.22	0.81	2.02	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	27.14	8.99	3.05	3.73	2.54	0.34	1.53	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	110.49	14.81	5.23	6.38	3.19	0.98	5.14	2.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.99	11.03	5.10	4.99	2.50	0.42	1.35	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.50	10.42	2.90	2.56	2.22	0.85	2.05	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.36	6.86	0.89	1.88	1.44	0.33	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.40	10.23	4.58	3.08	2.16	0.83	2.08	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.21	9.39	2.65	2.65	2.25	0.20	1.63	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	22.28	8.66	2.27	2.06	1.65	1.44	1.03	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	22.25	8.76	2.08	2.65	1.50	0.58	0.81	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	42.69	9.84	3.00	5.34	1.83	0.50	1.33	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.77	7.72	2.20	2.65	1.76	0.00	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.29	9.96	1.84	3.07	1.35	0.74	0.86	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.74	10.37	1.95	2.27	2.43	0.16	0.97	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.66	12.51	1.92	3.21	0.64	1.28	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.25	8.72	2.84	2.56	2.27	0.28	0.47	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	31.32	10.76	1.90	2.53	2.06	0.47	1.74	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.07	9.43	3.65	4.87	0.91	0.61	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	25.51	9.93	3.76	1.78	1.88	0.94	0.42	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	30.52	12.08	3.51	2.85	1.98	0.44	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.34	12.06	1.40	4.77	2.52	0.56	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.55	10.28	2.41	4.17	2.13	0.65	0.56	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.09	8.56	3.21	3.21	1.07	0.53	0.53	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	32.13	9.49	1.84	3.21	2.60	1.38	0.77	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.00	12.69	2.85	3.11	1.04	1.04	0.52	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.13	10.57	2.44	4.88	1.90	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.37	16.96	3.87	4.98	3.13	0.74	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	50.22	24.56	3.51	6.14	3.07	1.54	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	70.41	34.71	8.93	0.99	3.97	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	54.48	15.43	4.35	5.94	2.24	0.92	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.20	17.96	2.62	6.86	3.43	1.01	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	189.35	59.47	10.42	4.57	9.40	0.25	0.76	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2.99	2.59	1.19	0.20	1.00	0.60	1.79	5.37
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.01	2.31	0.92	0.46	1.23	0.00	1.54	3.70
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1.84	2.05	0.41	1.02	0.82	0.00	1.23	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2.82	1.56	0.63	0.00	1.56	0.00	4.38	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.26	1.98	0.28	0.28	0.57	0.00	4.24	3.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.31	0.00	0.46	0.00	0.00	0.00	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	4.95	0.00	2.47	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.22	5.42	5.03	0.77	2.32	1.55	6.96	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	3.21	4.81	0.00	1.60	0.00	9.63	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1.74	3.48	3.48	1.74	3.48	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	11.07	4.56	2.28	0.65	2.28	0.98	4.56	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.00	4.12	2.88	2.88	1.24	1.65	3.71	4.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	3.33	3.33	3.33	0.00	0.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.86	3.08	0.84	1.40	0.56	0.84	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.07	6.86	3.60	2.94	2.29	1.31	5.23	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	6.71	1.68	0.84	3.36	0.84	0.84	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	13.04	2.54	2.54	1.91	2.23	0.95	1.91	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.28	3.74	2.04	2.38	0.68	0.68	4.08	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	4.18	0.00	0.00	0.00	2.09	2.09	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.33	2.29	4.01	4.01	2.86	1.72	2.86	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	17.17	2.37	1.48	5.03	0.30	2.96	1.78	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	6.78	3.39	1.69	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	1.66	1.66	2.49	0.41	0.83	1.66	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.27	2.76	0.69	1.15	0.69	0.69	1.15	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	0.00	5.27	10.54	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.91	1.92	2.69	0.77	1.15	0.00	1.54	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.32	0.98	1.63	2.28	1.30	1.96	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	25.42	2.68	1.34	2.01	1.34	0.67	3.34	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	31.21	4.24	3.08	5.39	1.54	1.93	2.31	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.29	6.50	3.08	3.77	0.68	1.71	4.11	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	4.97	2.48	2.48	0.00	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	22.18	3.30	2.36	2.83	0.47	0.94	1.42	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.14	3.62	1.81	4.22	0.00	1.21	3.62	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	1.02	1.53	1.02	0.51	0.00	4.07	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.36	1.99	2.39	1.60	0.40	1.20	1.60	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	32.07	3.45	1.97	1.48	0.99	0.99	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	3.54	0.00	2.36	0.00	0.00	0.00	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.25	3.50	2.33	2.33	1.75	0.58	2.33	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.43	3.51	0.88	3.51	0.44	0.88	1.76	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	3.39	0.85	0.00	1.70	2.54	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	17.31	3.58	2.98	2.39	1.79	1.19	1.19	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	1.46	0.97	2.91	0.97	0.00	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	65.05	20.54	2.28	2.28	3.42	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	73.18	6.65	6.24	11.23	6.24	1.25	1.66	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	129.31	16.87	12.37	9.00	10.12	0.00	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.98	8.25	2.54	3.49	0.95	0.63	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.57	3.76	3.76	5.43	1.67	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	17.06	11.84	2.55	3.37	0.81	0.46	0.70	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.84	10.13	2.53	2.87	1.52	0.68	0.51	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.61	8.42	0.91	2.28	2.28	1.37	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.12	10.82	1.64	2.95	0.98	0.98	0.77	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.75	10.32	0.86	2.15	0.86	1.29	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.33	10.33	1.94	2.37	2.15	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.44	11.21	1.87	2.62	1.12	0.50	0.62	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.49	9.09	1.20	2.06	1.72	0.51	0.86	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.78	14.42	0.64	0.96	1.60	0.32	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	91.78	19.03	1.12	8.95	2.24	1.68	2.24	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	171.39	21.64	6.49	11.25	5.19	4.33	2.60	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	116.33	21.15	10.58	15.86	0.00	10.58	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	57.14	8.11	2.82	2.12	3.88	0.71	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	75.56	12.35	2.91	5.09	5.81	1.45	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	54.20	5.07	1.92	4.90	2.27	1.40	1.22	1.22
Hepatocyte, donor1	11523-119I2	2.42	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	12.93	0.00	2.15	1.08	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	16.57	4.29	1.23	2.45	0.00	2.45	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	34.59	8.48	1.96	2.61	2.61	0.00	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	8.56	1.22	1.40	0.87	0.70	0.35	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	86.03	14.27	4.25	4.25	3.57	1.37	2.47	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	171.93	89.15	6.37	15.92	3.18	0.00	6.37	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	140.18	100.13	6.68	6.68	0.00	6.68	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	27.08	0.00	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	174.43	53.99	12.46	19.38	8.31	2.77	5.54	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	115.12	90.10	7.51	22.52	0.00	5.01	2.50	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	59.34	0.00	11.87	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	140.96	82.01	10.25	38.44	2.56	10.25	7.69	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	150.84	41.14	4.57	9.14	4.57	4.57	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	253.40	73.09	14.62	37.36	17.87	6.50	8.12	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	161.73	73.36	11.67	26.68	6.67	6.67	5.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	87.13	68.98	0.00	14.52	0.00	10.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	230.28	76.76	13.23	31.76	7.94	3.97	6.62	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	131.93	69.84	6.65	27.72	11.09	4.43	5.54	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	94.29	26.19	15.71	10.48	0.00	15.71	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	158.10	51.65	8.82	25.19	6.30	2.52	3.78	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	114.45	64.96	17.01	12.37	4.64	6.19	1.55	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	73.17	0.00	43.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	224.82	64.60	16.15	23.90	11.63	6.46	5.17	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	193.19	135.23	11.27	22.54	9.66	8.05	8.05	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	47.79	0.00	11.95	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	288.47	68.45	18.74	25.26	13.85	4.89	5.70	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	297.23	81.44	12.17	17.21	12.59	5.88	6.30	4.62
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	198.51	66.71	15.27	27.33	5.63	4.02	4.82	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	137.57	71.09	6.46	17.54	3.69	6.46	3.69	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	45.24	0.00	45.24	0.00	15.08	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	129.81	47.68	13.69	14.63	7.55	4.72	2.83	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	112.47	63.49	6.35	15.42	1.81	6.35	4.53	6.35
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	88.45	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	178.64	60.26	12.91	25.83	9.69	5.38	1.08	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	182.95	113.07	12.70	27.95	5.08	5.08	8.89	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	49.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	227.65	66.96	17.86	36.99	8.93	5.10	1.28	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	151.28	103.89	3.65	27.34	10.94	7.29	9.11	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	209.22	74.98	16.42	37.85	5.71	6.43	2.14	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	159.28	56.41	19.91	23.23	0.00	9.95	16.59	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	83.39	20.85	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	122.54	51.24	9.88	17.59	5.56	4.94	2.78	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	136.97	107.12	8.78	33.36	5.27	10.54	0.00	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	62.86	3.14	9.43	3.14	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	170.37	66.76	7.65	21.56	7.65	5.56	3.48	4.87
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	170.41	101.80	19.92	11.07	8.85	2.21	8.85	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	119.95	74.57	9.73	19.45	0.00	3.24	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	219.73	64.52	13.08	33.13	6.98	8.72	2.62	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	114.74	94.49	13.50	13.50	18.00	2.25	2.25	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	146.35	52.27	17.42	20.91	0.00	13.94	3.48	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	132.28	67.21	18.14	23.47	6.40	5.33	4.27	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	191.19	78.97	18.01	9.70	5.54	4.16	5.54	8.31
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	128.23	45.59	8.55	8.55	2.85	8.55	11.40	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	199.73	56.15	17.49	29.45	5.52	5.52	2.76	9.20
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	114.96	36.30	21.18	18.15	3.03	12.10	3.03	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	86.92	93.13	0.00	6.21	0.00	12.42	6.21	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	108.91	49.70	13.75	25.38	5.29	1.06	0.00	3.17
Keratinocyte - epidermal, donor1	11272-116H3	83.72	5.71	5.63	4.00	2.28	0.57	0.82	0.41
Keratinocyte - epidermal, donor2	11349-117G8	50.36	8.20	2.93	1.17	1.17	0.59	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	65.69	7.57	4.35	5.11	3.03	0.76	1.23	0.47
Keratinocyte - oral, donor1	11251-116E9	77.19	14.42	4.88	3.75	3.63	1.36	0.79	0.23
Keratocytes, donor1	11527-119I6	51.23	11.00	3.44	1.38	2.75	0.34	0.69	0.34
Keratocytes, donor2	11607-120I5	62.11	2.34	2.34	3.52	1.17	1.17	0.00	2.34
Keratocytes, donor3	11688-122I5	56.71	11.66	3.36	5.53	3.36	1.19	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	4.40	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	58.25	6.47	3.24	7.55	4.31	1.08	0.00	5.39
Lens Epithelial Cells, donor2	11609-120I7	46.36	9.69	3.92	1.50	4.84	0.58	1.27	0.58
Lens Epithelial Cells, donor3	11690-122I7	110.70	46.72	7.97	2.83	5.65	0.30	2.12	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	73.40	8.42	3.32	3.79	2.02	0.59	1.19	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	65.58	4.47	1.95	5.86	0.28	0.56	1.67	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	63.12	6.30	1.42	7.08	0.79	1.42	1.10	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	41.94	1.61	3.23	2.69	0.54	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	68.39	5.04	1.89	4.10	0.63	0.32	2.21	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	66.95	4.42	2.48	6.04	1.08	1.51	0.86	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.94	3.69	2.87	3.69	0.41	1.23	1.64	2.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	88.49	8.09	2.02	4.55	1.01	1.26	2.28	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	75.86	7.88	2.82	7.04	0.99	0.99	0.70	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	47.86	3.56	1.98	3.16	1.98	0.40	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	76.58	7.76	0.97	3.30	1.74	1.36	0.97	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	71.65	7.41	2.41	4.44	0.37	0.74	2.78	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	67.25	6.62	0.70	4.53	1.39	1.05	0.35	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	89.68	6.44	1.91	3.10	1.67	0.24	1.19	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	70.60	7.97	1.37	6.18	0.69	0.69	1.37	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	65.29	6.47	1.85	5.24	1.54	0.92	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	71.08	6.23	1.25	3.43	0.94	1.25	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	98.08	7.87	3.29	5.67	1.46	1.28	0.91	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.90	3.95	1.32	4.28	0.99	0.00	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	76.73	10.25	1.76	5.86	0.59	1.17	1.17	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	89.12	8.21	3.98	9.96	1.24	1.49	1.00	2.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	65.96	5.33	1.45	3.88	1.45	0.00	1.45	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	75.40	4.58	2.15	4.31	0.54	1.62	1.35	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	85.23	7.27	2.57	6.06	0.61	2.12	1.67	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	53.40	7.26	0.00	1.56	0.52	1.04	1.56	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	83.13	5.23	3.56	3.77	1.68	1.26	1.05	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	87.52	9.47	2.41	5.86	1.20	1.20	1.20	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	55.03	3.44	1.38	5.50	0.00	1.38	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	88.24	6.77	1.88	5.08	0.75	0.75	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	89.81	9.22	4.56	8.16	1.27	1.38	0.74	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	69.29	7.27	2.91	2.91	1.45	0.48	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	87.33	7.61	2.65	6.28	0.99	0.99	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	92.18	10.78	2.60	9.04	1.73	0.87	1.98	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	70.71	7.03	3.33	4.07	1.11	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	72.15	3.46	1.98	2.96	1.73	0.74	1.48	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	88.96	8.39	2.61	6.46	1.79	1.37	0.82	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	73.66	5.15	1.61	4.18	1.29	0.00	1.93	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	77.30	6.70	1.52	5.17	1.52	1.52	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	80.90	9.24	2.66	7.14	1.82	0.98	1.26	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	70.76	3.91	1.78	4.98	1.07	0.71	0.71	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	86.29	6.79	1.45	5.82	0.48	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	104.88	10.43	3.27	6.07	1.40	0.47	1.56	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	55.86	6.80	2.86	6.45	0.72	0.72	0.72	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	87.88	7.19	1.96	1.96	0.98	0.00	1.63	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	71.80	9.42	1.88	4.24	0.47	0.47	2.12	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	94.30	8.79	1.98	5.32	1.86	1.11	1.49	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	96.05	7.43	4.35	5.12	1.02	1.28	0.51	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	63.25	11.04	4.18	5.97	2.69	1.19	0.30	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	18.13	9.06	0.00	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.06	28.38	3.07	3.07	5.37	2.30	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	16.33	0.74	5.20	2.23	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	40.62	20.73	3.81	8.46	0.85	2.12	0.85	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	44.31	23.21	4.22	7.74	2.81	2.81	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	22.42	28.02	5.60	2.80	0.00	1.87	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.46	17.52	3.61	14.43	2.06	4.64	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	29.74	21.41	0.00	1.19	2.38	2.38	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	42.52	16.29	4.07	1.81	3.39	0.90	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.76	11.05	1.74	5.53	1.74	0.58	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.06	22.51	2.70	5.85	0.45	2.70	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	63.68	25.20	5.69	4.74	2.30	1.08	1.90	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.84	17.46	3.59	8.73	2.57	2.05	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.64	17.64	2.82	2.47	2.47	0.71	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	16.66	17.32	0.67	1.33	0.67	1.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	33.62	16.81	4.58	9.68	2.55	1.53	2.04	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	30.95	19.21	2.40	6.14	2.13	0.80	1.60	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.58	20.78	3.97	6.80	3.21	1.32	1.13	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	39.88	20.86	6.14	7.36	1.84	1.84	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.03	36.69	1.63	10.60	4.08	0.00	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.15	20.41	3.33	7.50	2.29	1.25	0.62	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.83	15.97	1.96	8.41	1.68	3.08	1.40	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	30.91	2.06	9.27	2.06	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	30.19	24.10	3.48	7.84	2.03	2.90	1.74	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.21	19.13	2.99	4.78	0.90	0.90	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.00	28.77	2.77	5.53	2.77	2.21	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	50.55	28.28	4.60	18.03	4.24	3.89	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.82	19.18	3.32	6.27	2.95	2.21	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	21.87	0.00	4.61	4.61	4.61	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	42.98	35.69	3.84	6.52	3.45	0.77	1.15	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	40.20	32.27	1.70	12.45	2.83	7.36	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	33.64	32.82	0.82	8.20	3.28	2.46	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	44.74	33.44	5.87	9.94	1.81	2.71	2.26	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.96	22.26	2.87	6.46	0.00	0.72	0.72	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	31.37	39.59	2.99	5.23	4.48	4.48	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	59.45	31.96	5.57	18.95	5.20	3.34	1.49	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.06	26.71	1.29	5.17	1.72	3.02	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	52.23	47.10	3.43	6.85	1.71	3.43	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	50.64	40.65	4.66	14.33	4.00	3.00	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	50.07	24.74	6.03	9.65	3.62	0.60	1.81	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	46.21	40.53	2.13	5.69	2.13	3.55	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	55.68	34.72	3.09	11.69	2.75	3.09	1.37	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.99	35.96	3.76	13.42	2.15	4.29	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	51.85	57.91	2.69	10.10	2.69	2.02	0.00	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	53.71	47.78	5.56	19.63	2.22	4.44	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	43.03	27.91	4.65	3.49	3.49	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	38.08	38.08	3.17	5.29	0.00	1.06	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	58.02	40.82	5.20	14.41	2.40	3.20	1.60	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	39.98	15.99	4.36	7.27	2.91	1.45	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	52.89	32.19	3.07	6.90	1.53	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	46.86	27.62	0.99	10.36	3.45	2.47	2.47	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	34.81	14.11	3.76	14.11	2.82	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	39.72	29.67	2.51	8.05	3.52	1.51	1.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.51	30.19	6.31	11.27	3.60	2.25	2.25	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	22.37	3.44	10.33	3.44	1.72	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	53.44	32.06	4.45	9.80	5.34	2.67	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	46.92	21.90	3.13	12.51	1.96	1.56	0.39	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	20.45	2.64	4.62	1.32	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	32.69	23.87	3.11	6.75	4.15	1.04	1.04	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.01	25.38	2.63	20.57	1.31	3.06	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.58	16.21	1.12	5.03	1.68	1.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	36.21	31.36	3.09	6.62	1.32	1.77	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	44.36	34.33	6.56	6.17	2.70	3.47	1.93	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	30.89	22.79	2.53	7.09	2.53	1.01	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.68	30.28	4.81	6.25	1.92	0.96	2.40	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	42.54	32.60	3.18	10.73	4.77	2.39	2.39	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	37.67	26.13	4.25	12.76	0.61	1.22	2.43	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	33.89	2.77	8.99	1.38	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	57.00	37.24	3.42	13.68	4.18	1.90	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	43.38	25.82	5.16	10.84	0.52	1.03	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	45.35	35.67	4.23	8.47	4.84	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	51.02	37.39	3.80	15.53	2.22	3.80	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	43.18	30.92	4.80	8.53	2.13	1.07	3.20	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	36.20	27.01	4.60	6.90	4.02	1.72	2.30	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.74	42.17	3.60	15.43	2.06	4.63	1.54	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.88	24.76	3.54	12.03	4.24	3.54	2.83	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	38.59	48.24	6.24	14.19	2.27	1.70	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	56.16	34.53	4.16	12.90	3.74	2.91	2.91	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	61.08	39.94	3.92	16.44	1.57	6.26	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	40.92	44.68	5.43	12.53	3.34	1.25	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.46	44.14	5.58	13.94	4.18	2.32	2.32	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	48.84	28.77	2.68	10.70	2.68	1.34	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	48.65	49.19	2.14	5.35	4.81	4.28	1.07	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	65.46	48.49	7.27	12.93	2.83	5.66	2.02	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	67.00	32.12	2.75	5.51	0.92	1.84	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	55.12	48.90	7.11	10.67	1.78	8.00	1.78	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	71.80	66.10	5.70	9.12	6.27	2.28	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	75.92	33.74	3.83	13.80	2.30	2.30	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	55.81	58.00	4.38	19.15	3.83	3.28	2.19	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	70.38	60.14	3.12	11.58	4.90	1.34	2.67	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	103.20	53.81	6.50	7.28	4.42	1.04	4.16	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	56.36	61.67	3.32	14.59	3.32	1.99	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	103.93	83.14	10.39	22.86	2.08	6.24	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	130.60	15.73	3.65	2.51	1.60	0.91	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	88.45	44.96	4.04	5.14	4.40	0.37	2.20	1.28
Macrophage - monocyte derived, donor3	11389-118C3	144.98	37.75	3.28	8.52	6.03	1.44	1.57	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	18.05	1.06	2.12	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	30.26	2.69	2.54	2.54	1.11	0.16	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	42.95	4.45	1.95	2.78	2.50	1.25	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	48.03	11.46	3.59	2.09	2.99	0.30	0.50	0.10
Mammary Epithelial Cell, donor2	11350-117G9	33.01	6.37	0.87	1.16	1.74	1.16	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	55.12	8.98	4.49	2.24	3.49	0.00	1.25	0.00
Mast cell - stimulated, donor1	11487-119E2	213.55	124.06	4.75	6.78	0.00	6.78	4.07	1.36
Mast cell, donor1	11563-120D6	261.27	44.88	5.08	11.35	2.05	5.30	1.62	0.65
Mast cell, donor2	11565-120D8	313.52	49.63	13.08	20.51	6.24	10.10	2.38	0.89
Mast cell, donor3	11566-120D9	365.15	62.58	16.43	18.69	5.18	10.36	1.58	2.03
Mast cell, donor4	11567-120E1	433.29	52.83	15.96	22.16	7.09	7.09	2.48	2.30
Mast cell, expanded and stimulated, donor5	11940-126A5	161.24	110.78	4.21	17.41	4.21	4.10	2.33	1.33
Mast cell, expanded and stimulated, donor8	11942-126A7	555.08	105.06	8.17	65.96	4.67	15.18	6.42	3.50
Mast cell, expanded, donor5	11939-126A4	183.44	14.45	4.93	12.50	1.49	6.08	2.87	1.15
Mast cell, expanded, donor8	11941-126A6	463.44	23.77	10.54	37.66	3.01	8.87	5.36	1.34
Melanocyte - dark, donor1	11502-119F8	181.19	8.46	1.89	7.16	2.29	1.89	3.18	1.59
Melanocyte - dark, donor2	11582-120F7	72.68	16.96	2.77	7.61	2.42	2.42	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	12.60	3.40	1.23	0.94	0.58	0.14	0.14	0.22
Melanocyte - light, donor1	11274-116H5	31.97	6.11	3.29	1.41	1.65	0.24	0.94	0.00
Melanocyte - light, donor2	11351-117H1	29.35	5.46	3.41	2.05	1.36	0.00	1.36	1.36
Melanocyte - light, donor3	11423-118G1	28.62	4.34	6.07	0.87	1.73	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	13.54	3.12	1.25	1.77	0.62	0.31	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	35.50	11.03	3.77	4.57	1.08	0.81	0.27	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	7.23	1.87	0.00	0.80	0.27	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	71.58	20.97	14.27	3.23	11.54	0.74	2.61	2.61
Meningeal Cells, donor2	11573-120E7	77.91	28.61	6.60	7.92	6.60	0.88	2.20	3.08
Meningeal Cells, donor3	11654-122E7	139.04	19.40	15.57	8.31	8.23	2.20	4.08	2.04
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.06	7.13	3.99	4.28	2.85	0.00	1.71	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	100.53	20.53	3.92	5.13	1.71	0.81	1.31	1.71
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	141.93	34.17	21.03	5.26	14.46	1.31	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	82.41	10.47	17.01	2.62	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	98.31	24.40	6.46	10.05	5.02	2.15	2.87	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.07	10.80	3.39	3.39	2.96	1.48	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.14	7.54	2.01	3.02	2.01	0.00	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	41.97	7.25	3.08	1.54	2.42	0.88	0.88	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	53.33	17.53	0.73	3.65	1.46	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	62.20	10.64	1.84	4.09	1.23	0.61	1.02	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	28.26	5.96	1.39	2.08	1.25	0.14	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	88.10	17.10	4.83	3.35	2.60	1.49	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	118.02	13.03	5.13	5.66	3.16	0.92	0.79	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	96.44	27.60	4.45	6.23	2.67	2.37	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	77.07	28.03	4.67	7.01	9.34	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.64	10.89	1.92	4.48	1.92	1.28	1.92	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	105.62	15.95	5.67	4.61	4.96	0.71	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	77.87	6.88	4.69	4.07	2.50	0.94	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	30.48	5.08	2.90	1.45	2.90	0.00	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	40.57	5.04	2.65	1.06	2.39	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	36.53	7.01	5.51	0.50	3.50	0.50	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	39.96	5.35	2.02	2.17	1.73	0.87	0.43	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	374.04	126.93	16.20	0.00	13.50	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	128.56	36.94	6.16	10.34	5.42	0.49	0.74	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	169.02	43.58	4.12	5.01	6.77	0.88	0.88	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	172.85	44.94	6.91	0.00	3.46	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	73.15	21.39	4.96	4.34	1.55	0.62	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	121.97	32.57	4.15	4.98	6.02	0.83	1.04	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	166.76	44.00	4.63	0.00	9.26	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	140.65	31.03	6.51	11.26	3.00	0.50	0.75	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	186.66	37.24	6.52	5.59	3.72	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	233.59	38.93	38.93	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	132.09	28.65	5.08	12.40	3.66	0.81	0.61	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	150.47	27.72	4.75	5.15	5.54	0.40	1.58	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	171.03	34.21	17.10	8.55	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	69.91	26.55	2.65	14.16	3.54	4.42	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	129.94	21.28	4.94	5.70	3.42	1.90	0.76	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	200.02	38.16	6.58	0.00	5.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	102.93	19.10	3.40	11.25	2.12	1.70	1.27	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	97.61	34.99	6.45	1.84	3.68	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	112.96	22.95	5.07	7.75	2.09	1.49	0.60	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	192.82	82.16	10.06	0.00	6.71	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	407.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	76.53	16.81	1.51	12.04	1.25	2.01	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	136.66	24.24	4.75	4.75	4.28	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	140.99	24.88	4.98	0.55	3.32	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	70.69	17.50	2.99	6.91	1.84	0.92	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	114.00	29.03	4.84	3.37	1.89	0.21	1.68	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	102.53	22.01	2.04	5.71	3.67	1.02	0.61	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	73.80	15.66	1.72	5.15	3.22	0.64	0.00	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	154.05	37.79	5.78	3.33	6.45	0.67	1.11	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	216.69	51.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	70.09	14.89	2.85	3.72	1.75	0.22	0.66	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	177.94	44.11	9.63	1.01	6.59	0.00	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	134.22	34.80	3.31	0.00	4.97	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	95.94	26.09	2.99	5.98	4.08	0.54	0.82	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	132.63	24.41	5.88	3.53	2.94	0.88	0.88	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	166.82	27.26	10.90	0.00	3.27	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	70.64	19.22	1.44	8.17	1.92	1.44	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	110.46	20.01	3.20	5.20	2.40	1.20	0.80	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	148.09	56.22	9.60	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	104.12	13.02	5.01	11.51	3.00	1.00	0.50	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	144.73	65.23	6.12	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	57.37	16.20	3.07	3.50	2.19	0.44	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	125.82	59.60	3.31	1.10	9.93	0.00	1.10	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	194.04	53.15	7.04	0.64	3.84	0.00	0.64	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	76.36	16.86	2.23	7.93	2.98	0.99	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	99.51	45.23	3.48	0.00	2.78	0.00	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	170.16	50.83	0.00	2.21	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	84.10	20.85	2.74	12.31	3.76	1.71	0.34	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	109.40	42.01	3.50	1.75	2.63	0.44	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	161.92	38.71	6.75	1.07	4.97	0.00	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	78.83	12.91	3.65	4.21	2.24	3.09	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	91.44	27.43	4.16	2.08	4.99	0.00	0.83	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	175.41	44.29	10.49	1.17	6.99	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	83.86	20.81	3.62	9.05	3.92	1.81	1.21	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	91.41	27.13	3.76	3.76	3.34	0.42	2.09	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	173.25	79.41	14.44	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	72.04	21.24	4.62	6.46	2.77	0.00	0.92	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	136.59	40.98	4.55	3.98	1.71	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	149.65	27.50	6.08	4.84	2.90	0.14	0.41	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	79.56	19.95	2.59	9.85	2.85	1.30	0.52	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	117.97	45.47	5.58	3.00	3.43	1.29	0.00	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	165.15	41.92	6.99	0.64	6.99	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	91.28	22.42	3.74	3.74	3.47	0.27	0.80	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	106.56	44.60	2.99	3.29	4.79	0.60	0.30	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	125.72	22.18	5.65	3.81	2.97	0.14	0.57	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	71.03	15.93	4.78	8.28	1.91	0.96	0.32	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	121.40	39.36	5.53	4.42	5.75	0.44	0.88	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	180.88	34.51	11.76	1.14	5.69	0.38	1.52	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	65.06	22.44	3.13	4.55	1.99	1.70	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	110.37	41.54	2.70	8.60	3.20	0.74	0.74	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	125.12	44.97	8.47	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	77.33	20.29	3.23	5.00	4.70	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	107.26	39.79	4.04	5.77	4.04	1.73	1.15	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	164.03	48.63	10.30	5.36	3.30	0.82	0.82	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	74.74	27.69	4.47	2.68	2.68	0.00	1.19	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	3.77	7.53	3.77	3.77	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	49.90	5.35	3.56	8.91	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	105.14	12.81	1.97	11.17	1.64	0.99	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	73.64	13.68	2.10	8.42	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	54.36	10.28	1.78	2.37	1.38	0.79	0.79	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	69.85	22.35	1.86	6.52	2.79	2.79	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	91.25	11.27	1.88	8.26	1.50	1.88	1.50	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	67.65	24.77	2.40	6.66	2.66	1.86	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	71.25	4.52	1.36	3.28	0.90	0.45	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	68.52	9.58	4.42	2.95	1.47	4.42	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	81.71	11.36	1.47	12.09	1.10	4.03	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	82.45	26.45	4.67	18.67	3.11	12.44	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	98.34	4.81	1.07	1.60	0.53	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	19.32	0.00	3.86	0.00	11.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	105.03	10.10	3.03	8.08	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	80.11	12.65	2.11	8.01	3.79	1.26	0.42	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	88.53	0.00	0.00	2.72	2.72	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	25.43	2.54	0.00	1.27	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.01	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	89.12	6.04	3.02	9.06	4.53	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	239.83	11.42	5.71	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	104.40	6.52	6.52	3.26	19.57	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	123.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	150.59	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	99.32	17.67	4.52	6.03	5.60	1.72	0.86	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	70.03	13.59	5.23	8.36	6.79	3.14	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.03	9.34	0.67	3.34	3.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	19.62	12.94	5.43	1.67	4.59	0.42	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.27	11.98	0.76	11.98	3.80	0.38	0.38	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	78.20	31.92	7.98	0.00	6.38	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	4.76	2.72	2.72	2.04	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	11.03	3.68	3.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.21	2.09	2.93	1.26	0.42	0.84	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	3.95	2.32	2.32	1.86	0.93	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	4.86	2.16	2.16	1.62	0.81	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.12	8.41	2.10	2.31	3.78	0.42	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.90	2.98	1.49	3.97	0.50	0.99	0.99	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.95	2.17	0.54	1.89	1.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.76	2.27	0.68	2.72	1.36	0.23	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.59	4.74	2.61	1.80	1.96	0.65	0.49	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.60	7.84	3.10	4.01	1.64	0.00	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	4.24	1.59	1.06	1.59	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	9.00	2.40	6.60	2.40	1.20	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.22	3.61	0.66	7.22	0.66	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	2.11	0.81	0.49	0.49	0.33	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	58.91	14.82	4.41	3.35	2.82	0.18	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	2.81	0.00	1.41	0.00	0.70	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.98	5.06	3.22	0.92	1.38	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.85	7.07	1.93	2.57	1.29	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	7.93	11.38	1.38	10.00	0.34	0.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	48.04	2.53	10.11	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	46.34	14.48	2.67	0.89	2.67	0.45	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.24	5.50	2.96	2.54	1.69	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.60	4.03	0.95	3.80	0.95	0.24	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.01	9.44	1.72	2.15	1.72	0.43	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	0.00	9.03	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	13.33	4.00	2.67	2.33	0.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	38.77	19.39	2.71	0.90	2.25	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.48	8.33	2.38	3.57	2.38	0.79	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	2.79	1.86	0.00	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.30	3.03	1.89	3.41	1.89	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.47	6.84	2.93	2.61	1.96	0.33	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.95	16.56	3.05	1.31	4.79	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	42.51	20.81	4.07	1.36	2.71	0.90	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	12.35	3.53	2.65	2.65	0.00	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	8.64	4.65	0.66	1.99	3.32	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	9.92	1.49	2.48	1.49	0.50	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.66	14.93	2.30	0.77	4.98	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.31	12.70	1.21	4.23	1.81	0.30	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	32.05	16.36	2.65	1.77	2.43	0.22	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	7.45	3.39	2.03	3.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	25.55	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	5.49	0.61	0.61	3.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.90	12.59	1.26	0.63	3.78	0.94	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.59	15.13	2.42	1.51	4.24	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	11.87	2.37	2.37	0.00	1.58	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	12.47	2.27	11.34	2.27	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	10.12	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	46.83	7.95	3.60	3.48	2.86	1.49	0.62	0.37
Myoblast, donor2	11322-117D8	90.72	24.55	4.22	12.08	4.41	3.26	1.15	0.58
Myoblast, donor3	11398-118D3	52.63	7.23	4.20	2.86	4.88	0.67	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	72.38	4.67	2.19	1.17	3.50	0.73	1.61	1.17
Natural Killer Cells, donor1	11230-116C6	671.31	16.91	61.81	20.30	68.88	8.61	4.31	3.08
Natural Killer Cells, donor2	11311-117C6	731.58	10.55	56.69	72.37	72.98	16.28	8.14	4.22
Natural Killer Cells, donor3	11387-118C1	615.84	9.94	53.19	30.92	64.05	5.15	4.97	2.02
Neural stem cells, donor1	11275-116H6	44.28	6.53	5.44	2.90	3.27	1.45	1.81	0.73
Neural stem cells, donor2	11352-117H2	36.59	7.70	1.93	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	13.65	2.28	1.14	3.41	1.14	1.14	0.00	2.28
Neurons, donor2	11574-120E8	14.09	0.88	0.44	0.44	1.10	0.22	0.22	0.44
Neurons, donor3	11655-122E8	7.40	3.29	0.82	4.93	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	583.72	47.33	53.82	42.69	19.49	66.82	5.57	0.00
Neutrophils, donor2	11314-117C9	547.89	52.18	31.89	78.27	11.60	81.17	11.60	0.00
Neutrophils, donor3	11390-118C4	578.47	48.26	42.15	23.21	14.66	100.18	2.44	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	40.73	6.77	2.85	3.92	3.09	0.47	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	52.42	10.09	5.21	2.28	1.63	1.63	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	19.45	3.01	0.60	1.40	0.60	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	49.83	18.31	4.54	9.36	3.03	1.51	0.69	0.14
Olfactory epithelial cells, donor2	11934-125I8	57.90	19.11	3.18	19.54	2.32	5.50	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	31.67	8.06	3.41	5.33	1.93	0.68	0.34	0.23
Olfactory epithelial cells, donor4	11936-126A1	68.47	14.90	5.84	4.09	4.29	0.39	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	45.14	7.22	1.81	1.20	4.21	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	49.98	19.57	6.38	1.70	7.44	0.64	3.40	1.06
Osteoblast - differentiated, donor2	11353-117H3	76.59	18.29	5.72	4.57	8.00	2.29	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	45.93	11.17	1.24	4.34	1.86	1.86	0.62	0.62
Osteoblast, donor1	11277-116H8	162.99	27.56	15.83	5.28	15.63	0.39	5.28	4.50
Osteoblast, donor2	11354-117H4	118.69	26.69	8.43	4.92	8.43	3.51	1.40	0.70
Osteoblast, donor3	11426-118G4	112.33	21.68	6.04	3.91	7.64	0.71	2.67	1.24
Pancreatic stromal cells, donor1	11249-116E7	25.35	4.97	3.71	2.36	2.11	0.76	0.59	0.34
Pericytes, donor1	11491-119E6	46.51	20.70	8.57	4.56	4.78	1.34	2.34	1.00
Pericytes, donor2	11571-120E5	39.61	22.41	4.98	4.75	4.75	1.13	0.91	1.58
Pericytes, donor3	11652-122E5	67.14	10.38	4.07	4.68	3.46	2.24	1.22	0.41
Perineurial Cells, donor1	11499-119F5	44.98	11.75	4.97	1.58	3.73	0.57	1.70	0.90
Perineurial Cells, donor2	11579-120F4	114.83	17.57	6.26	4.60	4.42	0.92	1.10	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	497.23	16.57	28.37	10.84	27.09	6.37	1.59	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	315.14	14.69	22.77	34.04	15.67	11.51	2.69	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	544.58	24.07	29.64	29.25	31.45	7.38	3.49	2.59
Placental Epithelial Cells, donor1	11278-116H9	29.42	3.11	3.35	0.96	1.43	0.72	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	36.59	5.54	6.65	4.44	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	46.14	6.28	7.66	2.55	3.93	1.37	0.59	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	47.78	11.08	5.70	13.29	4.43	6.01	1.90	2.53
Preadipocyte - breast, donor1	11467-119B9	59.84	7.69	6.75	5.25	3.38	1.31	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.97	20.49	1.44	1.44	0.65	0.26	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	75.42	15.99	4.05	12.83	5.85	4.50	2.93	0.68
Preadipocyte - omental, donor1	11468-119C1	35.16	4.80	6.18	2.98	0.96	0.43	0.00	0.32
Preadipocyte - omental, donor2	11329-117E6	79.44	14.40	7.86	5.67	5.67	1.75	1.31	1.31
Preadipocyte - omental, donor3	11403-118D8	52.29	12.32	4.73	3.29	3.72	1.72	1.43	0.72
Preadipocyte - perirenal, donor1	11469-119C2	27.56	7.87	0.98	1.97	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	135.75	28.56	9.21	3.38	5.84	0.61	3.38	3.38
Preadipocyte - subcutaneous, donor2	11356-117H6	65.34	14.70	5.67	11.16	4.60	3.54	3.19	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	64.88	33.55	6.98	7.32	4.77	3.07	2.38	2.72
Preadipocyte - visceral, donor1	11280-116I2	54.68	11.74	7.54	2.51	3.17	0.28	1.49	1.96
Preadipocyte - visceral, donor2	11357-117H7	81.91	16.57	6.44	11.50	3.68	3.68	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	56.11	14.94	4.70	7.21	2.82	1.78	1.88	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.34	4.22	1.96	2.87	1.36	0.60	1.06	0.75
Prostate Epithelial Cells, donor2	11331-117E8	47.53	5.96	2.98	6.50	1.35	1.49	0.95	0.68
Prostate Epithelial Cells, donor3	11404-118D9	44.27	11.45	2.63	4.16	2.27	0.92	0.37	0.18
Prostate Stromal Cells, donor1	11254-116F3	65.26	10.02	5.13	4.44	2.96	1.25	1.25	0.91
Prostate Stromal Cells, donor2	11332-117E9	60.78	9.68	5.02	8.43	2.15	0.54	1.43	1.61
Prostate Stromal Cells, donor3	11405-118E1	33.99	7.20	3.34	6.05	2.61	1.67	0.83	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	45.26	13.14	3.65	1.46	1.46	1.09	1.82	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	65.78	7.55	4.71	4.09	2.22	0.76	0.76	0.69
Renal Epithelial Cells, donor1	11517-119H5	117.68	19.27	9.64	5.58	9.13	0.00	5.58	4.06
Renal Epithelial Cells, donor2	11597-120H4	43.39	12.09	4.98	4.98	1.42	1.42	2.85	1.42
Renal Epithelial Cells, donor3	11678-122H4	118.89	13.76	5.50	6.88	3.39	1.80	1.06	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	99.40	12.26	2.04	12.94	1.36	0.00	0.68	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	76.28	7.95	2.16	6.06	1.35	1.08	0.81	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	115.00	17.98	2.66	13.54	1.78	2.00	1.11	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	222.92	51.90	7.99	12.64	3.33	7.32	1.33	3.33
Renal Mesangial Cells, donor1	11518-119H6	108.28	21.35	7.04	3.52	5.50	1.32	3.52	1.76
Renal Mesangial Cells, donor2	11598-120H5	79.63	18.81	8.15	6.90	3.76	0.63	1.88	1.25
Renal Mesangial Cells, donor3	11679-122H5	95.43	23.03	4.44	6.94	7.21	0.83	2.50	2.22
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.84	5.64	2.15	1.07	1.34	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.66	3.80	0.84	2.11	1.27	0.00	1.27	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.29	7.52	3.28	1.35	1.54	0.58	1.35	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	9.85	0.26	0.26	0.52	0.26	0.00	0.78	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	20.18	6.82	2.84	0.57	1.99	0.28	1.42	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	34.99	15.44	2.06	4.12	1.03	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	42.40	4.01	2.51	3.26	0.50	1.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	95.42	10.96	2.41	2.94	1.74	1.07	0.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	231.39	58.96	23.23	9.83	13.40	0.89	4.47	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	126.59	60.54	14.86	35.22	11.01	6.05	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	297.57	68.45	49.88	7.54	37.12	2.32	2.32	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	166.04	40.18	32.77	15.08	15.99	1.30	1.17	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	218.07	42.30	30.98	24.03	15.09	1.99	1.99	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	186.49	28.00	29.22	7.36	13.05	1.56	2.79	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	191.15	31.01	28.28	17.86	13.52	3.85	1.61	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	234.61	39.28	31.12	32.05	17.02	3.73	2.45	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	258.87	41.60	31.43	19.42	11.79	5.08	2.31	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	136.50	44.22	24.64	10.95	13.69	2.05	1.10	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	201.95	35.70	27.83	28.44	14.52	4.84	1.66	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	167.36	25.09	25.45	3.23	12.90	1.08	2.15	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	135.14	38.73	26.68	15.64	10.62	3.30	0.72	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	209.91	35.41	32.19	25.65	13.84	3.00	1.72	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	202.68	38.72	25.45	15.27	11.28	2.43	3.76	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	125.03	50.28	23.90	8.79	11.85	1.15	1.91	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	232.53	48.72	30.56	17.89	15.84	1.49	2.42	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	246.53	31.19	44.72	8.46	13.34	1.32	1.50	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	222.42	66.35	29.73	11.68	18.45	1.06	0.80	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	270.32	49.06	35.24	22.10	18.59	3.21	2.53	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	235.45	41.25	29.60	16.42	13.94	3.06	2.86	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	186.57	49.45	30.76	15.06	13.24	1.92	1.28	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	198.74	40.36	31.11	30.55	19.34	6.17	3.08	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	253.44	42.38	30.25	13.33	12.82	3.59	2.05	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	173.94	51.42	29.36	15.13	15.13	1.82	1.46	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	240.60	45.50	30.54	24.04	16.68	4.78	3.80	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	244.33	38.42	32.37	19.21	15.45	2.01	2.28	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	119.35	51.89	27.36	17.69	10.38	2.59	2.12	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	242.46	46.23	33.33	28.97	18.06	5.16	2.38	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	230.34	34.84	24.09	19.41	12.86	3.51	2.57	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	125.66	45.00	23.43	15.14	15.34	2.07	1.04	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	220.10	37.16	35.61	51.54	15.48	4.87	3.10	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	254.63	50.76	31.12	18.17	18.38	1.67	2.51	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	170.79	56.12	34.18	15.21	15.61	3.10	1.88	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	276.22	59.77	41.89	13.79	20.27	0.68	2.72	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	300.76	56.10	45.50	14.27	19.28	1.93	3.47	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	134.97	51.58	25.62	22.01	11.00	3.44	1.89	2.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	241.14	56.51	34.84	13.31	22.36	1.10	2.88	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	236.08	45.31	31.03	24.63	14.78	3.45	2.96	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	134.98	50.45	25.39	15.17	14.32	2.39	0.51	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	239.99	45.72	40.54	10.95	21.60	1.92	2.22	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	223.64	53.84	33.59	10.13	12.53	1.87	2.67	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	194.68	45.90	29.73	19.77	14.10	2.21	1.24	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	196.67	36.91	35.24	22.14	20.71	1.90	2.38	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	391.19	86.46	72.76	12.09	23.78	1.61	1.81	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	207.09	53.40	42.38	24.77	17.61	4.05	1.13	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	354.25	63.23	46.12	39.48	20.26	4.89	1.40	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	432.77	82.20	45.33	12.39	25.08	1.21	0.91	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	242.45	68.17	49.08	30.84	18.48	5.39	2.57	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	374.07	61.71	58.37	14.56	23.58	2.33	1.89	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	341.33	82.75	52.93	37.11	23.73	2.43	3.04	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	182.65	65.70	33.76	19.59	16.88	1.51	0.60	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	596.46	129.15	56.09	64.01	25.11	7.24	10.40	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	557.44	118.92	65.00	47.63	25.46	8.99	3.29	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	308.53	72.03	34.24	41.44	15.00	4.72	6.61	4.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	468.08	91.35	46.10	35.65	21.98	2.77	21.13	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	440.52	84.74	59.50	17.43	21.03	3.00	4.81	5.41
Schwann Cells, donor1	11498-119F4	64.13	15.05	6.02	5.64	7.52	0.75	2.07	1.69
Schwann Cells, donor2	11578-120F3	23.82	3.40	3.40	0.00	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	41.41	6.35	3.29	3.29	2.85	0.88	0.88	0.22
Sebocyte, donor1	11220-116B5	159.40	12.05	9.86	5.48	4.93	0.00	0.55	0.55
Sebocyte, donor2	11301-117B5	60.66	7.81	3.68	9.65	1.38	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	76.06	10.51	3.71	8.45	2.47	2.68	1.03	0.62
Sertoli Cells, donor1	11255-116F4	54.67	6.63	1.66	0.00	1.66	1.66	0.00	3.31
Sertoli Cells, donor2	11333-117F1	50.84	0.00	0.00	19.77	0.00	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	72.41	9.59	6.69	3.34	3.26	0.62	1.23	0.88
Skeletal Muscle Cells, donor2	11358-117H8	62.89	17.35	5.78	5.06	6.51	0.72	2.89	0.00
Skeletal Muscle Cells, donor3	11430-118G8	142.13	23.41	12.54	11.70	10.87	0.84	7.52	3.34
Skeletal Muscle Cells, donor4	11451-119A2	38.02	12.57	2.20	3.30	1.89	0.94	2.20	2.04
Skeletal Muscle Cells, donor5	11455-119A6	42.96	7.88	4.16	3.72	2.53	0.74	3.57	3.12
Skeletal Muscle Cells, donor6	11459-119B1	46.63	7.23	1.69	4.46	1.39	1.08	2.46	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	50.53	9.70	6.17	3.53	3.53	0.50	2.14	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	45.37	6.28	3.42	6.14	2.43	1.14	1.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	67.76	15.68	4.37	5.56	4.27	1.29	2.28	1.49
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	81.30	29.83	6.99	3.37	5.64	0.59	2.53	1.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	93.37	7.96	9.41	4.34	5.79	0.00	3.62	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	80.91	33.16	8.26	6.47	6.19	0.96	2.89	1.93
Skin - palm, donor1	10286-104F7	24.17	16.12	5.37	0.00	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.29	5.48	1.30	3.17	0.58	1.15	0.86	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	8.18	9.00	0.00	4.09	2.45	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	41.29	5.71	1.30	7.01	1.30	1.17	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	41.70	5.28	2.92	4.17	0.83	1.11	1.25	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	47.12	8.16	1.83	5.06	1.41	0.56	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	70.62	15.65	1.27	2.54	0.42	0.42	0.85	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	67.61	16.04	2.85	2.32	2.40	0.97	0.52	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	50.30	4.94	5.25	10.49	3.09	5.25	0.93	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	129.40	52.03	1.33	12.01	0.44	2.89	0.44	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	165.77	15.87	12.93	2.94	4.70	0.59	3.53	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	137.46	16.35	4.20	8.18	3.98	0.88	2.21	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	137.04	10.63	7.88	1.58	5.91	0.00	1.18	2.36
Smooth Muscle Cells - Aortic, donor3	11432-118H1	146.02	11.59	7.73	3.09	6.95	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	56.04	9.01	4.00	9.01	4.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	182.72	14.51	9.32	4.79	5.86	0.80	1.60	1.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	50.76	18.62	2.44	8.87	3.10	1.55	0.89	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	52.36	7.04	2.05	2.56	1.54	0.64	1.02	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.51	2.93	1.95	0.00	2.60	0.00	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.01	5.61	0.89	2.36	0.59	0.89	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.22	3.84	0.85	1.85	1.57	0.43	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	32.37	4.55	1.46	1.14	1.79	0.49	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.66	7.00	1.52	0.91	1.52	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	151.79	31.07	13.39	4.29	10.10	0.51	3.54	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	165.26	18.36	6.12	6.12	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	192.17	18.60	7.63	13.83	5.25	2.86	2.86	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.60	0.59	1.92	0.74	0.74	0.15	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.68	4.09	1.94	4.52	1.29	1.08	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.86	5.25	2.10	1.99	1.47	0.31	0.42	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	205.57	14.85	10.36	4.18	6.81	0.46	0.93	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	126.11	16.17	3.23	5.39	7.55	1.08	1.08	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	68.74	6.87	5.08	3.89	1.79	0.60	0.00	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.77	7.17	3.41	1.37	5.12	0.34	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	68.48	4.24	4.00	2.75	1.41	0.47	0.16	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	104.16	16.10	7.35	8.15	4.83	2.42	1.31	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	91.48	12.97	2.96	7.28	3.41	1.82	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	72.46	12.08	5.43	7.85	3.62	1.21	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	46.63	8.74	2.38	1.59	1.59	0.53	1.06	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	40.08	9.45	2.00	3.33	4.13	1.07	0.53	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	85.78	12.27	4.13	10.52	3.38	1.88	1.25	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.47	3.55	3.04	1.27	0.51	0.51	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	188.47	20.35	10.25	7.54	11.46	1.06	2.71	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	174.04	27.76	11.25	6.00	12.75	0.00	2.25	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	151.19	19.38	1.29	14.21	2.58	0.00	10.34	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	297.18	32.55	17.67	8.84	11.63	1.86	6.51	6.98
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	141.37	15.65	5.05	7.57	4.54	4.54	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	92.14	13.16	4.39	8.15	3.76	0.63	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	36.28	4.13	1.77	2.65	1.47	0.88	0.88	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	58.81	9.33	5.08	0.58	4.00	0.25	1.08	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	3.74	0.47	0.93	0.93	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	89.52	9.93	5.76	1.58	2.59	0.14	0.58	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	140.99	17.08	5.86	6.37	5.86	2.04	2.55	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	148.92	19.93	9.03	8.46	4.14	0.38	1.88	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	42.76	7.27	2.52	2.66	2.24	0.42	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	61.75	8.80	4.36	2.35	2.60	0.42	0.17	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	80.00	9.05	1.90	4.29	1.43	1.90	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	93.95	9.54	6.85	1.47	4.16	0.00	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	36.46	26.07	3.76	6.63	2.65	2.43	2.21	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	37.74	9.07	5.56	3.51	2.05	0.29	1.46	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.24	8.94	2.14	4.28	2.14	0.19	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.28	5.02	0.79	5.82	0.26	0.53	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.58	4.46	0.74	5.21	0.74	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.73	4.67	2.16	4.67	2.16	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.49	2.27	1.70	1.99	1.14	0.57	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	10.24	1.18	1.58	1.58	1.18	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	16.76	8.13	1.27	8.38	1.78	1.52	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	25.16	6.39	2.80	3.59	1.60	0.40	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	14.63	4.18	0.42	5.43	1.25	0.84	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	6.88	0.92	5.50	2.29	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	120.35	32.49	12.29	9.26	5.55	2.52	0.84	0.50
Synoviocyte, donor2	11368-117I9	22.13	9.22	3.18	2.51	2.35	0.34	0.50	0.17
Synoviocyte, donor3	11440-118H9	14.30	8.71	3.57	2.68	2.46	0.45	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	61.46	8.58	6.79	3.57	5.00	0.36	1.79	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	67.39	11.89	5.95	1.98	0.00	1.98	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	58.35	7.87	4.63	2.32	3.94	0.93	0.69	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	68.10	8.03	3.37	1.79	1.72	0.07	0.50	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	103.99	11.60	3.87	6.96	3.09	0.77	1.55	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	70.44	11.45	4.01	5.73	4.01	1.72	1.72	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	92.27	9.47	3.20	3.81	1.72	1.48	0.98	0.25
Urethra, donor2	10319-105A4	52.15	14.39	3.60	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	75.45	17.27	4.52	2.92	3.72	1.33	1.33	0.53
Urothelial Cells, donor2	11600-120H7	62.09	16.42	2.40	4.41	1.20	1.60	0.40	0.40
Urothelial Cells, donor3	11681-122H7	83.89	22.23	4.58	5.04	5.27	1.15	0.69	0.92
Urothelial cells, donor0	11216-116B1	108.55	17.39	5.57	5.13	6.24	1.78	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	415.53	27.58	16.02	30.25	21.35	32.92	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	401.72	15.73	11.44	25.73	17.16	41.46	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	506.54	26.01	5.48	36.28	13.69	30.80	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	358.80	15.50	12.40	15.15	9.64	16.53	2.07	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	365.47	11.62	13.36	18.59	8.13	22.66	1.74	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	356.10	21.87	9.37	24.99	13.54	35.40	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	339.58	23.86	5.51	21.11	18.36	26.62	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	516.70	21.00	12.78	43.82	20.08	27.39	7.30	1.83
Wilms' tumor cell line:G-401	10809-111A8	24.80	5.30	4.69	1.73	3.08	0.62	2.47	2.34
Wilms' tumor cell line:HFWT	10597-108E3	2.64	0.00	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.57	3.91	2.51	1.12	1.12	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	84.73	14.47	6.20	10.33	6.20	2.07	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	68.33	1.27	3.57	2.80	3.06	0.00	5.61	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	34.13	3.48	0.93	0.70	2.09	0.00	3.48	3.71
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	49.98	6.65	7.95	1.42	3.09	0.36	2.61	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	45.44	6.26	3.54	1.36	0.27	0.82	5.44	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	98.10	9.28	3.37	9.56	1.69	3.09	8.99	4.78
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	175.53	6.56	3.17	4.86	2.33	4.23	1.90	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	283.10	40.83	3.54	17.42	4.63	6.53	2.45	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	82.40	8.37	1.32	6.61	0.88	0.00	1.32	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	112.30	26.14	3.68	7.76	3.27	1.63	4.49	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	100.57	9.71	4.66	3.49	5.44	1.94	6.99	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	51.15	28.15	1.66	5.70	2.02	0.92	2.21	2.94
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	159.92	39.01	3.90	7.80	0.00	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	214.02	14.18	5.34	17.66	1.63	5.11	5.11	4.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	194.69	30.81	3.88	13.46	4.40	3.11	1.81	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	105.50	13.74	1.46	5.84	2.63	1.17	1.46	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	70.18	13.48	1.86	1.39	0.93	0.46	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	74.03	25.50	4.94	7.40	1.23	0.82	1.65	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	30.70	15.96	0.61	2.15	1.23	0.61	0.31	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	56.33	20.91	2.13	5.97	1.71	0.43	2.56	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	66.42	16.07	0.91	1.52	0.61	1.21	0.61	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	79.19	19.02	2.17	3.13	1.20	0.72	2.17	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	100.90	14.48	2.45	7.57	2.00	2.00	1.11	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	400.92	58.70	11.67	6.67	8.01	2.00	1.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	360.49	135.65	29.73	5.57	50.17	0.00	1.86	11.15
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	479.87	25.24	4.52	32.39	6.40	8.29	5.27	5.27
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	145.23	21.37	3.49	1.74	2.18	3.05	1.74	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	631.69	178.07	5.62	0.00	24.37	0.00	5.62	5.62
adenocarcinoma cell line:IM95m	10796-110I4	1.41	0.47	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	81.28	8.53	3.26	4.19	1.55	0.47	0.47	0.16
adipose, donor1	10184-103D4	0.00	2.93	0.00	0.59	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	5.68	2.43	0.41	0.41	1.22	0.00	0.00	0.81
adipose, donor3	10186-103D6	2.18	3.54	1.09	1.09	0.54	0.00	1.63	0.54
adipose, donor4	10187-103D7	4.33	5.20	0.87	0.00	0.00	0.00	6.07	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	36.61	8.05	3.47	0.32	5.52	0.16	2.05	3.79
adrenal gland, adult, pool1	10081-102A9	18.19	10.91	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	74.97	14.67	7.07	2.40	3.47	0.53	1.60	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	44.66	24.65	10.36	3.22	3.93	0.00	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	28.05	6.72	3.25	1.39	2.32	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	30.43	5.07	4.06	2.37	3.38	0.34	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	28.58	10.90	2.95	2.36	1.77	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	5.93	0.00	0.00	2.37	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	41.77	4.26	0.20	2.84	0.20	0.81	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	8.71	4.52	0.65	1.94	0.32	0.65	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	88.11	5.60	5.09	2.67	2.16	0.38	0.64	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	24.49	3.97	1.32	0.88	1.10	0.88	7.28	3.97
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.67	0.33	0.33	0.00	0.00	0.00	0.33	0.33
aorta, adult, pool1	10052-101G7	59.23	29.81	2.94	5.10	4.51	1.18	0.59	0.00
appendix, adult	10189-103D9	110.23	7.37	2.33	2.72	2.72	0.78	3.10	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.34
artery, adult	10190-103E1	13.59	2.72	4.08	2.72	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	94.31	18.54	13.62	3.04	9.71	0.87	1.01	1.30
b cell line:RPMI1788	10427-106D4	80.60	3.57	8.62	2.08	5.06	0.15	2.38	5.06
basal cell carcinoma cell line:TE 354.T	10702-109G9	40.78	10.82	4.16	1.94	2.50	0.83	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.00	8.34	2.68	0.99	1.98	0.10	0.50	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	0.67	0.33	0.00	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	80.53	27.96	3.36	2.24	1.12	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	89.74	14.88	5.32	5.11	2.72	0.65	0.11	0.00
blood, adult, pool1	10053-101G8	228.11	13.29	13.29	24.36	8.86	31.00	8.86	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	20.55	3.43	0.86	8.56	0.00	0.00	0.86
bone marrow, adult	10192-103E3	209.87	21.59	7.42	33.07	4.05	8.77	1.35	2.02
brain, adult, donor1	10084-102B3	15.38	0.00	2.05	4.10	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	25.84	2.67	0.45	1.78	0.67	0.00	0.11	0.11
brain, fetal, pool1	10085-102B4	5.34	5.34	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	37.66	15.20	2.97	0.99	0.99	0.33	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.25	0.12	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	42.93	12.00	1.26	4.42	2.53	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.49	10.42	0.76	3.43	1.14	0.38	0.89	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	12.99	4.02	0.93	1.86	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.56	27.63	4.60	10.59	1.38	2.30	1.15	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	33.41	16.70	3.87	0.97	2.91	0.48	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	7.05	0.47	0.47	0.00	0.47	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	97.79	15.86	4.48	1.09	6.56	0.55	1.31	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	6.65	1.58	0.95	1.58	0.00	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	8.78	4.26	0.80	0.80	1.06	0.27	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	14.97	3.45	0.00	2.30	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	39.49	2.68	1.00	2.34	1.00	0.33	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	14.52	3.06	0.00	0.76	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	9.89	2.20	1.10	2.93	0.37	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	0.00	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	16.44	2.56	1.28	1.28	0.85	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	10.00	0.34	1.38	0.00	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	4.98	0.00	2.49	0.83	1.66	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	19.41	3.28	1.26	1.76	0.76	0.00	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	23.39	3.65	0.73	1.46	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.29	0.29	0.00	0.00	0.14	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	27.18	10.77	2.15	0.50	2.82	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	88.09	14.17	7.35	3.25	3.67	0.63	0.42	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.44	2.51	0.84	1.95	0.84	0.28	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	58.78	20.90	5.23	0.00	6.53	0.00	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	32.06	6.46	4.10	2.73	1.62	0.62	1.49	0.12
choriocarcinoma cell line:SCH	10785-110H2	3.82	0.74	0.62	0.25	0.12	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	31.78	21.82	2.61	0.47	3.32	0.24	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	57.84	16.24	4.56	2.85	3.13	0.85	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	61.75	13.42	5.17	3.98	2.19	0.20	1.49	0.00
chorionic membrane cells, donor3	12240-129G8	79.13	19.78	12.09	9.89	4.40	3.30	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	3.03	1.01	2.02	1.01	4.04	2.02	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	174.62	32.46	2.31	7.30	3.84	1.54	2.11	3.07
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	80.88	24.92	3.17	0.84	4.01	1.06	3.17	2.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	114.02	42.12	7.19	10.02	4.11	0.26	1.80	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	150.21	54.91	10.40	8.47	5.32	0.73	2.18	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	160.44	88.37	10.99	10.99	6.72	1.43	2.04	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	85.69	32.10	7.36	5.30	4.12	1.18	6.77	4.71
chronic myelogenous leukemia cell line:KU812	10409-106B4	321.09	37.79	8.08	7.56	6.52	1.56	4.95	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.34	10.06	3.20	4.11	0.00	1.37	1.14	1.60
clear cell carcinoma cell line:TEN	10636-108I6	17.52	10.41	2.08	1.21	0.52	0.35	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	13.55	3.11	1.46	1.10	1.28	0.55	0.55	1.46
colon carcinoma cell line:COLO-320	10420-106C6	9.50	2.66	1.52	0.00	0.38	0.00	0.76	1.52
colon, adult, donor1	10082-102B1	28.56	7.14	1.19	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	65.80	4.70	3.17	1.76	0.94	0.59	0.47	0.94
colon, fetal, donor1	10070-101I7	18.54	5.56	0.62	1.85	0.00	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	357.51	36.67	4.58	0.00	0.00	0.00	0.00	18.33
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.50	4.25	3.40	0.85	0.42	0.00	1.70	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.81	12.38	4.23	1.81	1.96	0.45	5.89	4.98
cord blood derived cell line:COBL-a untreated	10449-106F8	27.36	13.11	3.24	0.99	2.12	0.14	6.91	4.23
corpus callosum, adult, pool1	10042-101F6	82.37	4.64	1.99	1.33	1.11	0.33	0.00	0.11
cruciate ligament, donor2	10295-104G7	51.87	21.07	4.05	7.29	1.62	1.62	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	18.46	7.22	0.80	2.41	5.62	0.00	0.80	0.80
diencephalon, adult	10193-103E4	15.84	0.96	0.72	0.48	0.00	0.48	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.72	0.69	3.21	4.36	2.30	0.92	3.44	2.76
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.85	2.05	0.77	0.00	0.51	0.00	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.87	3.13	1.44	1.20	1.44	1.20	1.69	0.96
ductus deferens, adult	10196-103E7	29.40	15.45	3.99	5.98	1.00	1.00	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	11.52	2.88	1.44	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.10	4.41	0.74	6.62	0.00	3.68	0.74	0.00
dura mater, adult, donor1	10041-101F5	153.94	17.18	12.22	5.78	6.52	0.74	0.58	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.32	6.44	1.55	2.00	0.44	0.67	5.33	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.92	8.02	2.87	1.00	1.00	0.00	6.02	2.87
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	15.42	12.33	0.00	4.93	0.00	1.23	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	34.51	9.69	4.24	2.42	1.82	0.61	0.91	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	41.68	14.51	8.03	1.23	2.16	0.31	0.93	0.62
embryonic pancreas cell line:2C6	10603-108E9	38.09	21.02	2.63	0.00	7.88	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	58.99	19.78	11.40	1.01	5.36	0.00	2.35	3.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	56.55	12.51	12.51	4.71	5.80	0.91	1.81	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1.77	0.16	0.00	0.64	0.32	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	68.47	19.23	8.00	0.67	6.45	0.33	0.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	77.32	11.99	7.48	2.09	7.26	0.77	1.43	1.32
epididymis, adult	10197-103E8	37.89	13.81	3.35	3.35	1.26	0.42	0.42	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	69.01	8.34	7.81	3.02	2.84	1.06	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	17.70	2.75	1.97	1.18	0.39	0.00	0.39	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	7.34	3.93	0.39	1.18	0.52	0.13	0.66	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	4.04	5.71	0.30	0.39	0.59	0.00	1.18	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	6.95	6.16	0.90	0.67	0.78	0.34	0.78	0.45
esophagus, adult, pool1	10015-101C6	65.83	10.83	3.82	4.46	2.65	0.21	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	4.63	5.26	0.50	0.38	0.38	0.13	0.63	1.50
eye - muscle inferior rectus, donor1	10272-104E2	7.24	2.41	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	42.08	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	7.44	0.00	0.00	1.49	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	30.96	5.73	3.44	3.44	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	40.81	4.37	2.91	7.29	4.37	4.37	1.46	0.00
eye, fetal, donor1	10054-101G9	30.76	8.39	1.53	3.05	2.29	0.51	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	69.11	13.72	3.21	3.21	2.95	0.90	1.41	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	83.33	13.06	3.80	2.37	3.09	0.24	1.19	2.14
frontal lobe, adult, pool1	10040-101F4	21.02	1.88	0.94	0.66	0.47	0.38	0.28	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	3.90	0.90	0.00	0.00	0.60	0.00	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	70.04	24.41	10.24	2.38	3.66	0.18	0.18	0.55
gall bladder, adult	10198-103E9	52.63	9.42	3.14	2.66	1.69	0.72	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	318.35	7.52	19.86	9.66	22.01	8.59	4.83	3.22
gamma delta positive T cells, donor2	11938-126A3	376.48	8.22	21.66	17.18	23.16	7.47	3.73	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	53.65	10.77	1.90	6.76	3.38	0.84	1.90	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	6.00	14.51	1.74	0.19	2.51	0.00	0.77	0.97
gastric cancer cell line:AZ521	10549-107H9	51.81	10.66	6.56	1.97	2.95	0.49	2.30	2.95
gastric cancer cell line:GSS	10560-108A2	0.92	0.00	0.92	0.92	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	98.24	3.66	4.11	11.19	1.37	2.51	1.37	2.06
giant cell carcinoma cell line:LU65	10487-107B1	7.92	3.21	1.72	0.92	0.46	0.11	0.11	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	99.93	22.67	5.46	1.96	2.94	0.14	1.26	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.46	8.98	2.49	1.00	1.50	0.25	0.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	83.91	8.34	11.72	1.48	4.43	0.21	0.21	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	65.02	11.66	9.55	1.40	3.51	0.28	0.84	0.28
glioblastoma cell line:T98G	10485-107A8	38.52	13.80	3.64	1.43	3.09	0.33	2.32	1.10
glioma cell line:GI-1	10413-106B8	79.66	24.89	6.15	2.34	4.39	0.29	1.76	0.59
globus pallidus - adult, donor10196	10175-103C4	9.48	0.73	0.00	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	80.31	5.37	2.93	3.42	2.20	0.49	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	9.58	8.22	0.00	1.37	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	9.06	1.60	0.53	1.07	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	269.19	19.58	4.89	0.00	4.89	0.00	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	52.16	9.92	3.52	3.52	3.52	0.96	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	0.46	2.30	0.00	1.84	0.00	0.92	3.21	6.89
hIPS +CCl2, biol_rep2	14384-156C1	0.91	3.20	0.00	0.91	2.74	0.00	0.46	4.12
hIPS +CCl2, biol_rep3	14385-156C2	0.64	3.22	0.00	1.29	1.29	0.00	0.64	8.37
hIPS, biol_rep1	14380-156B6	0.00	4.31	0.00	0.00	0.00	0.00	1.44	12.94
hIPS, biol_rep2	14381-156B7	0.00	3.43	0.00	0.69	0.00	0.69	2.06	8.92
hIPS, biol_rep3	14382-156B8	4.41	2.21	0.00	2.21	0.00	1.10	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	92.52	6.61	3.16	4.02	3.74	1.15	3.45	1.44
heart - mitral valve, adult	10205-103F7	51.42	14.65	1.79	4.19	2.39	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	41.57	7.84	2.88	1.31	1.31	0.00	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	65.78	19.15	0.00	4.16	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	17.96	3.88	1.22	2.24	1.02	0.41	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	23.42	6.39	0.85	2.55	0.85	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	46.92	6.44	2.53	1.15	0.23	0.23	0.23	0.23
heart, fetal, pool1	10046-101G1	48.16	9.04	3.29	0.51	1.75	0.31	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	32.40	16.66	3.39	0.62	2.47	0.62	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	3.57	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	56.35	10.83	4.42	4.31	6.19	0.99	1.88	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	52.07	11.77	4.85	4.49	6.31	1.34	2.55	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.57	11.62	4.95	5.05	8.49	0.91	2.22	1.82
hepatoma cell line:Li-7	10484-107A7	30.25	12.57	3.67	1.67	3.00	0.44	1.45	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	56.58	3.92	2.41	1.31	3.42	0.40	4.82	3.92
hippocampus - adult, donor10196	10169-103B7	11.36	0.00	0.00	0.00	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	53.47	3.47	1.63	2.25	0.82	0.61	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	1.49	0.50	0.00	0.00	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	9.87	1.06	0.35	0.70	0.70	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	0.00	1.83	1.22	0.61	0.00	1.22	1.83	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	2.36	4.12	1.96	0.79	1.18	0.39	4.52	5.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	3.30	2.29	0.51	1.02	2.29	0.25	3.55	4.57
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.00	1.13	0.00	0.56	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.81	0.52	0.00	1.03	0.00	0.26	0.26	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1.90	0.38	0.38	0.76	0.76	0.38	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1.17	0.58	0.88	0.29	0.29	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.09	0.43	1.51	0.65	0.86	0.22	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.09	0.83	1.25	0.83	0.42	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	4.74	0.95	0.47	0.24	0.24	0.00	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	5.79	2.25	0.32	1.45	0.00	0.48	1.13	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	0.67	2.02	0.00	0.00	0.00	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.13	1.56	0.47	0.16	0.47	0.78	3.60	4.54
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.49	0.98	0.98	0.98	0.49	1.97	3.44	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.87	2.62	0.00	1.75	0.00	0.87	2.62	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1.53	2.29	0.76	0.57	0.00	0.19	0.76	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	2.62	3.49	0.00	0.87	0.00	0.44	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	0.00	0.00	1.00	0.50	0.50	0.00	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.67	1.13	2.26	2.07	1.13	0.00	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.00	1.36	1.82	1.36	0.91	0.00	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.39	0.63	1.88	0.31	1.57	0.31	0.31	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.21	2.45	0.65	1.63	0.33	0.33	1.47	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	5.52	4.94	0.29	0.87	1.45	0.00	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3.89	3.29	0.90	1.20	0.60	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.24	3.88	1.48	1.85	1.29	0.74	6.10	6.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	8.84	3.99	2.28	0.86	1.14	0.57	4.56	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2.86	4.90	1.63	2.04	3.67	0.82	6.53	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.11	2.11	1.06	1.41	0.35	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	4.12	0.95	0.32	1.27	0.95	0.00	0.63	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1.82	0.30	1.51	0.91	0.00	0.00	1.21	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.65	2.59	0.00	0.52	0.00	0.00	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	0.66	0.66	0.66	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.33	0.51	0.77	0.26	0.26	0.00	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.69	3.32	0.00	1.53	0.26	0.00	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	4.54	1.51	0.00	0.00	0.00	0.76	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.74	6.72	0.34	2.35	0.67	0.00	0.67	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.11	4.35	1.69	1.69	0.48	0.48	5.07	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	5.35	4.90	1.78	1.34	0.89	1.78	3.12	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	5.37	2.93	0.49	1.46	0.49	0.49	2.44	7.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.53	1.83	0.31	0.00	0.31	0.00	0.61	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	3.25	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1.32	1.32	0.00	0.33	0.33	0.00	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	3.83	1.64	2.19	1.64	0.00	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.51	0.36	0.72	1.09	0.00	0.00	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	2.49	0.36	0.00	1.07	0.00	0.36	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	1.19	0.00	3.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	4.20	3.11	0.41	0.41	0.95	0.14	0.95	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	3.77	2.96	0.54	0.81	0.00	0.00	0.81	0.27
immature langerhans cells, donor1	11904-125F5	71.68	31.72	7.26	5.09	3.63	0.48	0.48	0.97
immature langerhans cells, donor2	11905-125F6	106.94	29.31	7.92	4.75	7.92	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	26.31	3.60	1.23	0.76	0.76	0.28	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	24.39	13.01	4.55	0.98	4.23	0.33	0.98	0.00
kidney, adult, pool1	10017-101C8	62.08	6.31	4.21	2.90	1.60	0.60	0.20	0.10
kidney, fetal, pool1	10045-101F9	69.53	12.31	3.89	2.05	2.41	0.92	0.35	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	60.93	15.91	4.83	1.70	4.26	0.00	1.14	1.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.52	4.42	1.38	2.90	0.69	0.00	0.14	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.66	13.76	3.30	0.37	3.49	0.00	1.10	0.92
left atrium, adult, donor1	10079-102A7	21.25	10.35	3.27	5.45	1.63	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	15.17	6.57	0.51	1.01	0.51	1.01	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	24.35	13.68	2.19	0.82	5.75	0.00	3.83	4.10
leiomyoma cell line:10964C	10569-108B2	56.40	6.83	3.95	11.14	1.44	1.44	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	45.65	5.43	1.09	10.87	0.54	1.09	0.54	1.63
leiomyoma cell line:15425	10571-108B4	58.03	10.93	3.16	11.41	3.40	4.37	0.24	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	148.47	96.19	27.18	11.50	14.64	0.00	3.14	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	403.05	57.38	11.22	10.15	17.35	3.07	4.96	3.90
liposarcoma cell line:KMLS-1	10782-110G8	17.50	15.00	1.87	2.66	1.56	0.16	0.94	0.62
liposarcoma cell line:SW 872	10726-110A6	52.39	12.91	4.39	1.46	4.39	0.12	0.37	0.49
liver, adult, pool1	10018-101C9	28.68	3.57	1.78	1.13	1.13	0.81	0.00	0.16
liver, fetal, pool1	10086-102B5	36.69	3.76	0.00	2.82	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	26.83	4.37	0.87	0.44	0.44	0.29	0.87	0.29
locus coeruleus, adult, donor10252	10165-103B3	46.69	4.61	1.48	1.66	0.55	0.55	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	13.54	2.26	0.85	0.85	1.41	0.56	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	17.67	4.21	0.00	3.79	0.42	0.00	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	22.00	9.41	1.80	0.69	0.69	0.42	0.55	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	53.77	38.61	10.34	0.69	9.65	0.69	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.98	20.56	6.33	1.19	4.61	0.13	0.53	0.79
lung, adult, pool1	10019-101D1	149.31	12.29	5.67	3.90	2.24	0.83	1.42	0.71
lung, fetal, donor1	10068-101I5	48.52	8.28	3.14	2.85	1.71	0.86	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	72.86	25.66	7.33	9.16	5.96	0.46	0.92	0.46
lymph node, adult, donor1	10077-102A5	82.84	12.31	3.79	9.47	1.42	8.52	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	44.27	8.77	2.63	1.97	1.53	1.10	1.75	3.29
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.58	0.45	1.96	0.75	0.91	0.30	4.83	2.87
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.13	10.19	4.25	1.70	1.70	0.85	0.85	0.85
mature adipocyte, donor1	12231-129F8	3.55	0.89	0.44	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	11.00	0.42	1.04	0.00	0.42	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	4.98	0.47	0.24	0.24	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	1.84	0.26	0.00	0.00	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.48	0.24	0.00	0.00	0.00	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	28.69	2.76	1.47	1.47	0.37	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	1.59	0.95	0.00	0.64	0.32	0.64	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	2.56	0.85	0.00	1.71	0.00	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	12.32	1.18	0.68	2.70	0.34	0.51	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	30.77	3.61	0.64	1.06	0.21	0.64	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	0.00	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	4.31	2.51	0.72	1.79	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	10.38	4.54	0.65	1.95	0.65	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	61.92	7.28	1.70	2.79	0.77	1.24	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	70.28	4.98	2.37	0.90	1.55	0.49	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	23.96	1.39	1.39	2.43	0.00	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	99.41	25.46	11.51	11.07	1.55	1.33	2.21	4.21
medulloblastoma cell line:ONS-76	10759-110E3	81.56	19.20	4.89	1.59	5.87	0.24	2.69	1.96
melanoma cell line:COLO 679	10514-107E1	18.26	4.31	1.15	0.57	0.43	0.29	0.29	0.14
melanoma cell line:G-361	10465-106H6	1.36	1.63	0.27	0.00	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	170.95	26.05	3.62	22.97	1.63	3.44	1.27	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	1.56	0.00	0.26	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	86.54	26.08	8.59	8.90	8.44	1.53	1.69	1.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	60.71	22.18	3.27	4.36	4.91	1.09	1.64	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	30.23	15.74	4.14	2.90	4.14	0.41	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	40.04	11.24	4.78	2.95	3.79	0.56	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	49.49	17.91	3.47	4.81	2.50	1.16	0.58	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.23	12.49	2.78	2.78	2.08	1.39	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.87	5.66	3.26	2.23	0.69	0.51	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	50.72	16.10	3.22	4.60	3.45	1.15	0.69	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	94.84	18.30	5.04	7.83	5.17	1.72	1.72	1.86
mesenchymal precursor cell - cardiac, donor4	11755-123G9	62.25	11.21	2.97	4.32	1.62	1.22	0.68	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	77.39	7.68	3.70	3.56	1.71	0.14	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.26	11.20	2.96	1.65	0.33	0.33	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	69.19	17.30	4.57	3.32	3.32	0.28	1.11	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	53.76	10.82	5.59	8.03	4.54	1.05	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	59.62	17.76	3.06	6.53	4.70	0.82	0.61	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.27	16.18	2.52	2.88	0.36	0.72	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	87.62	15.72	4.66	7.66	3.62	1.76	0.62	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.74	4.10	1.60	3.65	0.91	1.37	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	27.27	3.36	1.68	5.03	1.26	0.84	0.00	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.00	4.03	1.20	2.84	1.79	0.60	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	82.72	9.28	4.11	5.25	1.93	1.14	0.53	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.98	6.26	2.21	2.95	0.74	1.10	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.19	7.15	2.58	3.43	1.14	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	11.79	2.11	0.84	1.26	0.00	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.93	10.05	3.20	3.20	4.57	0.91	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	41.44	11.77	5.12	3.84	4.09	0.51	1.28	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	47.12	12.56	3.66	2.09	3.66	0.79	1.05	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	51.14	12.63	7.09	8.63	1.85	0.62	1.23	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	46.36	11.30	3.06	6.35	2.82	0.71	0.94	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	44.00	9.14	4.74	6.09	2.03	0.68	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	44.41	10.61	5.50	3.14	5.11	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	40.31	6.49	5.10	5.56	3.71	2.32	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	51.34	15.86	3.17	4.61	2.60	1.15	0.87	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	43.73	15.62	4.69	3.35	5.13	0.67	1.12	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	46.87	11.78	4.57	6.49	5.29	0.72	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	66.00	28.60	8.07	3.67	2.93	0.73	1.47	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	43.97	9.40	4.36	3.36	2.35	1.01	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	39.71	15.15	3.68	6.14	2.46	1.64	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	49.40	10.31	6.44	4.73	4.30	0.00	1.29	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	5.47	8.20	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	5.16	0.00	10.33	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	32.48	7.47	1.95	4.55	3.25	0.32	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	13.09	1.45	1.45	4.36	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.25	9.60	3.73	4.26	3.20	2.13	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	34.35	3.27	1.64	6.54	4.91	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	35.37	8.16	2.72	3.89	1.55	0.78	1.17	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	4.20	4.20	4.20	4.20	0.00	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	32.78	10.93	1.99	3.97	0.99	1.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	4.77	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	28.46	8.89	1.19	2.37	2.37	0.00	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	41.43	7.31	1.22	7.31	0.00	0.00	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.00	11.40	3.80	2.53	5.07	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.87	3.10	0.69	1.38	0.00	0.69	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	6.45	0.00	2.15	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	3.44	3.44	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.82	5.30	1.22	2.04	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	18.27	4.77	0.79	3.18	0.00	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.92	4.13	1.77	1.18	1.77	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.29	4.36	0.94	2.49	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	2.67	2.67	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	7.10	0.00	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	2.57	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	8.26	0.69	1.38	0.69	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.45	0.99	0.49	0.49	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	2.24	1.12	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.09	1.27	0.00	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.04	0.81	0.81	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	0.00	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	0.00	0.00	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.25	0.00	0.61	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.12	0.82	1.65	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.97	3.17	0.79	0.00	0.60	0.20	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.24	5.19	0.65	0.00	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	5.09	3.06	3.06	1.02	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	199.62	41.78	13.15	0.77	16.25	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	78.67	16.06	15.83	1.65	5.43	0.00	0.94	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	33.36	3.24	5.10	1.39	1.39	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	8.55	0.00	4.27	4.27	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.60	5.65	2.88	1.64	2.06	0.31	0.51	0.31
mesothelioma cell line:Mero-25	10850-111F4	51.52	5.67	3.40	3.86	1.59	1.36	1.82	2.04
mesothelioma cell line:Mero-41	10851-111F5	60.87	11.49	5.62	6.85	1.47	0.73	0.24	1.22
mesothelioma cell line:Mero-48a	10852-111F6	48.49	7.75	4.65	4.65	2.66	0.89	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	39.95	4.47	3.42	3.68	1.84	0.79	0.53	1.31
mesothelioma cell line:Mero-83	10854-111F8	81.71	13.62	3.57	9.19	2.21	2.21	2.38	1.19
mesothelioma cell line:Mero-84	10855-111F9	50.81	8.34	2.53	3.03	1.01	1.77	0.76	1.26
mesothelioma cell line:Mero-95	10856-111G1	24.64	3.73	1.66	2.07	0.41	0.62	0.62	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	55.82	4.14	2.82	3.48	1.82	1.33	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	40.90	5.07	3.26	4.89	1.45	0.72	0.72	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	34.16	6.15	0.68	1.88	0.34	1.02	0.68	0.51
mesothelioma cell line:NCI-H28	10845-111E8	42.75	12.47	5.34	8.40	1.78	0.51	2.04	1.78
mesothelioma cell line:No36	10857-111G2	95.58	21.53	5.87	6.20	2.94	1.63	1.96	0.98
mesothelioma cell line:ONE58	10858-111G3	37.39	8.13	2.98	5.42	0.54	1.63	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	6.91	0.58	1.92	0.77	0.77	0.19	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	9.04	0.61	2.32	0.49	0.61	0.12	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	5.74	0.72	1.62	0.36	0.90	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	49.30	12.41	5.22	8.81	5.22	3.59	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.02	6.78	4.24	1.91	3.18	0.42	1.48	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.96	23.50	2.76	0.00	2.76	0.23	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	35.01	13.51	4.00	2.28	3.23	0.19	3.62	3.23
myelodysplastic syndrome cell line:SKM-1	10772-110F7	129.35	21.81	3.70	5.54	2.40	0.92	2.96	2.22
myeloma cell line:PCM6	10474-106I6	77.29	12.85	5.14	3.95	3.95	1.58	2.57	2.37
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.24	18.77	8.62	0.51	6.09	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.52	10.40	2.94	0.59	2.75	0.20	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.83	6.46	1.11	0.67	0.78	0.22	0.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.34	6.62	0.81	0.66	0.66	0.22	0.44	0.07
nasal epithelial cells, donor2	12227-129F4	46.37	12.70	2.76	0.55	2.21	0.55	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	3.68	0.46	1.61	0.46	1.84	0.23	5.06	3.91
neuroblastoma cell line:NB-1	10539-107G8	17.59	7.11	3.18	1.12	0.75	0.00	4.49	3.55
neuroblastoma cell line:NBsusSR	10607-108F4	1.48	2.53	0.00	0.00	0.63	0.00	0.42	0.84
neuroblastoma cell line:NH-12	10555-107I6	1.30	0.19	0.00	0.00	0.00	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	16.84	3.08	0.95	3.56	0.95	0.47	0.47	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	129.40	37.69	6.97	11.40	5.86	2.53	5.54	2.85
neuroectodermal tumor cell line:TASK1	10774-110F9	12.48	5.43	1.01	0.81	1.41	0.00	2.82	2.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	79.47	45.14	6.99	0.64	4.45	0.64	3.81	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	55.10	16.24	3.73	1.33	3.73	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	2305.60	14.87	14.87	0.00	29.75	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	13.28	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	198.88	0.00	18.94	9.47	0.00	113.65	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	87.10	4.90	2.71	2.20	2.71	0.17	3.55	3.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	0.00	0.00	0.00	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.55	15.07	3.21	3.21	2.24	1.92	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	29.69	8.67	4.47	2.36	1.31	2.36	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	30.09	2.91	0.84	0.94	0.75	0.00	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	46.43	3.49	0.81	1.88	2.15	0.54	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	9.83	2.91	1.09	0.00	1.46	1.09	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	16.79	0.52	0.79	1.31	1.84	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	3.86	2.15	0.86	0.86	0.00	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	24.99	2.44	1.10	0.47	0.79	0.16	0.32	0.00
olfactory region, adult	10195-103E6	16.05	1.91	1.15	2.67	0.76	0.19	0.00	0.00
optic nerve, donor1	10277-104E7	24.01	6.00	2.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	47.50	14.81	4.67	1.94	3.65	0.57	0.23	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.38	1.92	1.92	0.41	0.96	0.00	1.51	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.84	10.84	2.71	5.25	1.86	0.85	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.45	10.40	2.08	1.50	1.27	0.35	0.58	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	129.05	32.04	7.64	5.59	8.53	1.47	1.18	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	303.66	94.37	18.69	0.93	10.28	0.00	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	67.22	17.81	4.45	3.18	3.18	0.85	1.27	1.48
ovary, adult, pool1	10020-101D2	48.92	8.56	2.80	2.01	2.36	0.70	0.52	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	56.28	20.53	3.85	2.57	6.23	0.18	0.92	0.55
pancreas, adult, donor1	10049-101G4	20.69	6.58	0.00	0.94	3.76	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.75	1.40	0.84	0.28	0.28	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	17.21	5.45	1.02	5.11	1.70	0.51	1.02	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	44.21	12.75	6.62	1.99	3.81	0.00	0.83	0.66
paracentral gyrus, adult, pool1	10035-101E8	20.68	2.11	0.46	0.64	0.82	0.18	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	0.73	0.73	0.00	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	7.52	0.00	0.00	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	22.52	2.00	0.86	1.71	0.00	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	21.50	1.32	1.15	0.26	0.70	0.09	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	3.88	1.94	0.00	0.00	0.00	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	10.47	3.74	1.12	1.12	0.00	0.00	0.00	0.00
parotid gland, adult	10199-103F1	20.35	1.23	0.00	1.23	0.00	0.62	0.62	0.00
penis, adult	10200-103F2	30.08	9.67	4.30	3.22	0.00	2.15	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.87	2.79	0.93	2.05	0.74	0.19	1.49	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.22	8.60	1.89	0.87	1.31	0.29	0.29	0.58
pineal gland - adult, donor10196	10179-103C8	7.74	4.52	0.65	1.29	0.65	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	20.14	4.15	1.18	1.18	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	10.66	5.02	0.00	1.88	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	8.09	8.09	0.00	1.01	1.01	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	28.14	5.21	0.52	0.00	1.04	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	6.81	2.55	0.00	0.85	0.00	0.85	1.70	0.85
placenta, adult, pool1	10021-101D3	178.67	30.53	5.16	6.34	3.55	2.04	0.75	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	52.57	4.50	5.43	3.18	3.97	0.53	1.85	2.12
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	115.17	17.90	5.60	5.60	5.45	1.09	0.47	0.31
pons, adult, pool1	10033-101E6	30.21	2.24	1.12	0.77	0.60	0.52	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	21.45	1.66	0.70	0.52	0.52	0.17	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	12.55	6.27	0.00	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	39.62	8.16	4.22	3.50	2.62	0.15	1.31	0.87
prostate cancer cell line:PC-3	10439-106E7	40.66	10.71	5.99	2.00	4.54	0.18	1.27	0.54
prostate, adult, pool1	10022-101D4	57.68	10.16	3.99	2.81	2.72	0.45	0.36	0.00
putamen, adult, donor10196	10176-103C5	21.25	2.12	1.42	1.65	0.24	0.24	0.00	0.00
putamen, adult, donor10252	10152-102I8	21.57	1.96	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	1.09	2.19	0.00	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	11.84	2.42	0.97	0.24	0.24	0.48	0.00	0.00
putamen, newborn, donor10223	10365-105F5	3.75	4.50	0.75	4.50	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	2.62	0.87	0.00	0.00	0.00	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	23.65	11.13	2.78	0.00	0.00	1.39	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	54.70	18.66	5.51	3.18	4.24	0.42	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	103.14	20.71	7.87	7.87	3.31	2.07	0.41	0.83
retina, adult, pool1	10030-101E3	43.34	10.54	2.68	1.89	1.99	0.60	0.50	0.00
retinoblastoma cell line:Y79	10475-106I7	28.32	4.94	5.20	1.82	1.82	0.26	4.68	5.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.94	2.09	1.35	0.12	0.61	0.00	0.12	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	7.03	4.22	2.25	0.00	1.69	0.28	0.56	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	93.22	22.74	7.58	0.00	3.03	0.00	1.52	0.76
salivary acinar cells, donor1	11771-123I7	42.57	29.13	4.05	4.21	2.91	1.13	0.16	0.65
salivary acinar cells, donor2	11772-123I8	28.09	21.07	3.17	5.23	3.17	0.69	0.28	0.41
salivary acinar cells, donor3	11773-123I9	45.02	29.79	4.63	0.66	6.62	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	15.44	0.57	0.57	0.57	0.00	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.86	2.87	2.53	1.35	0.84	0.17	0.34	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.16	3.76	2.00	1.06	0.94	0.35	0.24	0.12
seminal vesicle, adult	10201-103F3	38.62	21.16	2.65	3.17	0.53	1.06	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.34	1.70	0.24	0.49	0.00	0.00	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	40.01	6.04	4.78	4.03	2.26	0.50	0.25	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	4.01	6.02	5.02	3.01	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	6.31	0.94	0.81	0.40	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.11	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	6.32	9.03	2.32	0.52	1.68	0.00	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	0.71	0.71	0.71	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	26.87	5.76	2.40	1.08	0.84	0.24	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	17.09	6.03	0.00	2.01	1.01	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	6.79	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	21.46	13.26	1.26	2.52	1.26	0.63	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	19.68	1.67	2.33	0.33	3.34	0.67	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	54.85	5.67	7.56	7.56	2.84	1.89	3.15	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.08	0.77	0.19	1.35	0.00	0.00	0.19	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	0.49	0.16	0.33	0.00	0.00	0.00	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	10.29	1.29	0.48	1.13	0.00	0.32	0.97	3.38
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.22	0.22	0.87	0.00	0.00	0.22	0.00	0.00
small intestine, adult, pool1	10024-101D6	56.74	5.37	2.27	2.63	1.67	0.48	0.12	0.12
small intestine, fetal, donor1	10064-101I1	21.62	5.41	1.97	2.95	0.00	0.74	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1.03	1.03	0.51	0.00	0.00	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	31.01	7.50	2.58	3.62	3.36	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	0.27	1.61	0.27	0.00	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	30.05	4.13	1.84	4.59	0.46	0.46	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	70.57	4.73	2.76	1.18	1.58	0.79	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	2.77	3.46	0.00	4.15	0.00	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	31.71	4.88	1.83	2.44	3.05	0.00	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	19.29	2.30	0.92	4.13	0.00	1.84	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	74.08	25.69	4.93	2.39	8.36	0.15	0.90	0.75
spleen, adult, pool1	10025-101D7	202.87	12.34	8.59	4.96	5.51	4.07	0.99	0.66
spleen, fetal, pool1	10044-101F8	205.23	14.30	6.36	5.32	4.13	2.86	1.59	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	91.82	6.62	7.76	2.90	5.49	0.72	2.59	1.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	17.09	5.70	1.14	0.00	1.14	0.00	0.38	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.39	4.19	0.00	0.70	0.00	0.70	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.40	14.07	2.74	2.35	2.35	0.00	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.19	4.50	0.45	0.23	0.68	0.11	0.56	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.05	19.06	3.39	4.24	2.12	0.00	1.69	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.08	12.69	7.19	0.85	0.85	0.00	1.69	0.85
stomach, fetal, donor1	10062-101H8	20.29	5.34	0.00	0.00	3.20	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	31.90	5.13	0.00	2.28	0.57	1.71	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	59.20	5.61	1.04	2.70	1.45	0.42	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	3.10	2.07	0.00	0.52	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	16.96	3.53	3.53	2.12	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	14.21	10.78	1.60	1.15	1.60	0.23	3.44	3.44
temporal lobe, adult, pool1	10031-101E4	31.62	2.46	1.10	0.76	0.85	0.17	0.25	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.12	0.00	0.00	1.42	0.00	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.03	0.88	0.44	0.44	1.76	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	68.42	9.43	8.38	11.17	4.54	4.19	0.00	0.35
tenocyte, donor2	11765-123I1	34.72	7.63	4.20	5.72	1.53	1.14	0.00	0.00
tenocyte, donor3	11768-123I4	24.83	9.27	3.34	3.71	2.59	1.11	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.24	3.23	1.70	0.51	0.68	0.68	2.38	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	138.27	18.96	9.25	9.71	10.48	2.47	4.01	3.08
teratocarcinoma cell line:PA-1	10807-111A6	4.65	5.73	2.17	0.31	1.24	0.00	3.87	3.87
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.43	1.02	1.02	0.00	0.13	0.25	0.51	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.38	0.38	0.38	0.00	0.38	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	5.89	1.64	0.65	0.33	0.33	0.00	1.31	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.54	0.65	0.65	0.33	1.30	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	48.96	10.52	3.97	4.72	2.25	1.50	0.86	0.43
testis, adult, pool2	10096-102C6	23.46	8.12	1.80	4.06	0.90	0.00	0.00	0.90
thalamus - adult, donor10196	10168-103B6	11.04	3.31	0.00	1.10	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	68.14	2.19	1.56	2.50	0.78	1.09	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	4.62	0.00	3.08	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.21	0.99	0.33	2.47	0.16	0.99	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	2.30	1.15	0.58	2.30	1.15	0.00	0.00	0.00
throat, adult	10209-103G2	38.70	7.49	1.75	3.50	0.75	1.00	0.00	0.00
throat, fetal, donor1	10061-101H7	12.19	5.48	0.91	1.22	0.30	0.91	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	24.05	1.79	1.19	1.79	0.60	0.40	2.58	3.18
thymus, adult, pool1	10027-101D9	115.92	7.95	6.86	6.56	3.18	3.28	3.18	0.80
thymus, fetal, pool1	10043-101F7	125.52	8.94	5.20	3.64	3.12	1.66	1.77	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.53	5.45	2.39	2.79	0.80	0.00	0.27	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	25.42	6.15	1.12	0.42	1.40	0.14	1.12	0.28
thyroid, adult, pool1	10028-101E1	32.47	5.88	0.56	1.68	1.21	0.28	0.19	0.09
thyroid, fetal, donor1	10060-101H6	16.08	6.86	0.26	1.05	0.26	0.26	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	15.40	9.24	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	22.79	7.68	2.33	3.49	2.79	0.23	0.47	0.23
tongue, fetal, donor1	10059-101H5	15.76	9.06	1.18	3.94	0.79	0.79	0.39	0.79
tonsil, adult, pool1	10047-101G2	140.25	11.02	7.91	3.51	5.01	0.70	0.80	1.20
trachea, adult, pool1	10029-101E2	61.92	9.90	2.62	2.94	1.88	0.90	0.49	0.49
trachea, fetal, donor1	10058-101H4	13.85	6.92	1.15	0.77	1.92	1.15	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	62.71	21.61	5.67	2.48	5.67	0.35	1.06	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	19.35	4.46	2.23	0.41	2.63	0.00	0.10	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.35	4.70	3.76	1.57	0.94	0.78	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	74.20	28.54	5.71	0.00	5.71	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.12	14.14	4.99	1.19	4.40	0.17	1.95	1.78
umbilical cord, fetal, donor1	10057-101H3	41.73	12.52	2.09	6.26	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	48.63	17.40	3.75	2.90	2.90	0.34	0.34	0.17
uterus, fetal, donor1	10055-101H1	26.62	12.29	3.07	3.58	1.54	0.51	0.51	1.02
vagina, adult	10204-103F6	79.48	11.63	1.29	5.82	0.65	0.65	0.65	0.00
vein, adult	10191-103E2	113.54	9.64	5.04	9.64	1.32	3.73	1.53	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	54.74	4.27	5.87	2.14	5.07	1.07	2.67	2.14